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ABSTRACT   
Purpose 
The purpose of this dissertation was to explore perceptions of social isolation and 
social support in individuals with one of two rare lung conditions, alpha-1 antitrypsin 
deficiency (AATD) or sarcoidosis.  First, a dimensional concept analysis was conducted 
to identify key factors contributing to the phenomenon of social isolation. Next, an 
integrative review of existing instruments to measure social isolation was conducted to 
identify the most appropriate instrument for the study. Finally, a mixed-methods study 
was conducted to explore these phenomena in the two populations of interest. 
Problem 
Many rare diseases are chronic, complex and associated with other disabilities 
(M. Anderson, E. Elliott, & Y. Zurynski, 2013).  Over the past three decades, social 
isolation has been shown to be predictive of mortality and morbidity in both general 
populations (Brummett et al., 2001; House, 2001; House, Umberson, & Landis, 1988) 
and in populations with chronic conditions (Berkman, 1995; Berkman & Syme, 1979).  A 
review of the research literature revealed no published studies that explored this 
phenomenon in rare disease populations, and specifically, in rare lung diseases (Flavin, 
2015a).   
The specific aims of the dissertation were: 
• Aim 1:  To examine the phenomenon of social isolation through the lens of 





• Aim 2:  To conduct an integrative review of instruments designed to measure 
perceived social isolation  
• Aim 3:  To explore the perceptions of social isolation and social support in 
individuals with sarcoidosis or alpha-1 antitrypsin deficiency in a pilot study using a 
convergent parallel mixed methods design.   
Design 
A convergent parallel mixed methods study design, informed by social network 
theory (Heaney and Israel, 2008) guided the collection of parallel quantitative and 
qualitative data streams.   
Findings 
In the mixed-methods study, there were statistically significant differences in the 
Friendship Scale, MOS-SSS emotional support, positive social interaction and total 
scores between the alpha-1 and sarcoidosis groups, with higher scores observed in those 
with alpha-1 (indicating more social connectedness and perceived support).  Sarcoidosis- 
affected individuals who participated in support groups reported more social isolation as 
reflected in the Friendship Scale scores than those who did not participate in support 
groups (p=0.04).  This was not the case in the AATD population, where access to support 
did not significantly alter isolation scores.  Content analysis revealed six themes:  Self-
reflection, building connections, activities, knowledge, relationships and 
physical/psychological impact.  Triangulation revealed that scores on both instrument 






Individuals with rare conditions do perceive varying levels of social isolation and 
low social support that may not directly correlate with their reported access to support.  
The impact of these phenomena is multi-layered and influenced by one’s support 
network.  These findings merit further exploration in the form of larger studies that 
include more geographically and demographically diverse populations.  Findings from 
this dissertation are significant for nurses and other health care providers because they 
allow for a more complete understanding of the issues confronted by individuals and their 
family members who are faced with either one of these conditions. 
Keywords:  social isolation, social support, alpha-1 antitrypsin deficiency, 




1.1. Overview of Dissertation 
Many rare diseases are chronic, complex and associated with physical, intellectual 
or neurological disabilities (Anderson, Elliott, & Zurynski, 2013).  Over the past three 
decades, social isolation has been shown to be predictive of mortality and morbidity in 
the general population (Brummett et al., 2001; House, 2001; House, Umberson, & 
Landis, 1988) and in populations with chronic conditions (Berkman, 1995; Berkman & 
Syme, 1979).  A review of the research literature revealed no published studies that 
explored this phenomenon in rare disease populations, and specifically, in rare lung 
diseases (Flavin, 2015a). Despite the high number of individuals affected by rare diseases 
as a whole, rare disease patients report often feeling isolated and unable to get the 
information and support needed (Colledge & Solly, 2012).  This dissertation focused on 
investigation of social isolation in a subset of individuals with rare lung diseases, 
sarcoidosis and alpha-1 antitrypsin deficiency (AATD). 
The specific aims of the dissertation were: 
• Aim 1:  To examine the phenomenon of social isolation through the lens of 
dimensional concept analysis, identifying the qualities of the concept of social 
isolation and exploring the relationships between the qualities in order to define the 
essential meanings associated with social isolation 
• Aim 2:  To conduct an integrative review of instruments designed to measure 
perceived social isolation and examine the qualities of each, in order to choose the 
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most appropriate instrument(s) to measure the construct in the populations of 
interest.   
• Aim 3:  To explore the perceptions of social isolation and social support in 
individuals with sarcoidosis or alpha-1 antitrypsin deficiency in a pilot study using a 
convergent parallel mixed methods design.  We also sought to gain preliminary 
understanding of the effects of participation in support groups in these individuals.  
The overall objective of this study was to gain insight into perceptions of the 
social impact, particularly social isolation and social support, and its consequences as 
experienced by individuals with AATD and sarcoidosis.  The overarching question 
driving this proposal was:  To what extent do individuals with the rare lung diseases of 
AATD and sarcoidosis perceive the social impact and consequences of living with these 
diseases as documented via participant self-report and as measured by the Friendship 
Scale and the Medical Outcomes Study – Social Support Survey (MOS-SSS)?  The results 
of this study provide a framework to design future larger studies that could be used to 
validate the findings and ultimately, to develop and test interventions that could 
ameliorate these perceptions.  The long-term goal of this research trajectory is to refine 
hypotheses related to the perceived effect of living with a rare disease on social 
interactions and support experienced by individuals with AATD and sarcoidosis and to 
inform future intervention development.   
2. BACKGROUND AND PROBLEM STATEMENT 
An estimated 10% of Americans live with a diagnosis of one of the 6,000 to 8,000 
known rare diseases (Griggs et al., 2009).  More specifically, recognition of the 
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importance of research into rare lung diseases has been growing (Gupta, Bayoumi, & 
Faughnan, 2011).  The experience of living with a rare condition is complex and can 
significantly affect the individual’s quality of life (Cohen & Biesecker, 2010).  Current 
clinical practice views the management of rare diseases primarily from the biomedical 
approach, seeking to manage clinical physiologic symptoms (Budych, Helms, & Schulz, 
2012).  Less attention has been given to the psychosocial management of the impact of 
these conditions.  As these patients may have significant needs and barriers to access to 
care (such as geographical distance from an expert provider), alternative interventions to 
ameliorate the negative psychosocial aspects of these conditions must be considered.  In 
rare diseases, there is an increasing importance and presence of the patient as an active 
participant in their disease management and decisions (Aujoulat, Young, & Salmon, 
2012; Aymé, Kole, & Groft; Black & Baker, 2011; Johnson, Kirschenbaum, Mason, & 
Rush, 2005; Polich, 2012).  As such, this patient-centric focus calls for a parallel patient-
centered research approach, such as interpretive phenomenological analysis (IPA)(Smith, 
Michie, Stephenson, & Quarrell, 2002).  Before designing interventions, it is prudent to 
seek the voice of the patient.   
Many studies have adopted a population-based approach to rare diseases, but the 
patients’ viewpoint on having such a disorder has remained largely understudied 
(Huyard, 2009).  These patients can experience a myriad of psychosocial effects, 
including social stigma, lack of social support, and perceptions of social isolation.  Over 
the past decade, social isolation has garnered increased attention as an integral 
component of health (World Health Organization, 2002) and the link between social 
isolation and health was one focus of the National Research Council’s     (2001) interest 
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in integrative health.  In a recent review, Cacioppo & Cacioppo (2014) observed the 
negative impact that social isolation can have on executive functioning, sleep, and mental 
and physical well-being, ultimately resulting in higher rates of morbidity and mortality in 
various populations (Cacioppo & Hawkley, 2003; Cacioppo, Hawkley, Norman, & 
Berntson, 2011; Cornwell & Waite, 2009; Steptoe, Shankar, Demakakos, & Wardle, 
2013).  Despite confirmation of perceived social isolation in Internet chat rooms, support 
group meetings, and limited studies of rare disease patients (Black & Baker, 2011b; 
Coulson, 2005; Coulson, Buchanan, & Aubeeluck, 2007; Lasker, Sogolow, & Sharim, 
2005), there is a need for formal study of this phenomenon.   
This dissertation is significant because the qualitative component of this study 
affords a novel opportunity to gather, firsthand, patient perspectives on the social impact 
of rare disease to supplement baseline quantitative data. This mixed methods approach 
can be utilized to guide larger studies in more diverse populations of rare disease patients, 
with the goal of developing and testing interventions that can enhance social support and 
ameliorate the condition of social isolation.  This research is also aligned with the 
mission of the NINR, and specifically, the need to “develop strategies to assist 
individuals and their caregivers in managing chronic illness, including analyses of 
caregiver burden and cost-effectiveness” (National Institute of Nursing Research, 2011, 
p. 15).  This work provides preliminary insights into the experiences of these individuals, 
and may serve as a reference point to develop strategies to address the management of the 
social isolation component of these rare, chronic diseases.  Findings from this study may 
also be utilized to explore perceived social isolation and social support in other rare 
disease populations.  
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3. GAPS IN KNOWLEDGE 
Few published studies have explored the experiences of living with a rare disease; 
no published studies were identified that explored social isolation in rare lung diseases 
such as AATD or sarcoidosis.  Two studies conducted in the rare disease of scleroderma 
identified social isolation as a phenomenon experienced by these individuals.  Joachim & 
Acorn (2003) conducted a phenomenologic study to investigate the perspective of living 
with scleroderma and identified persistent themes of stigma and isolation.  In their study 
of scleroderma patients, Cinar and colleagues (2012) found similar themes, including 
social isolation.  Henderson and colleagues (2009) investigated the general psychosocial 
impact of living with Niemann Pick disease Type B, a rare lysosomal storage disorder; 
they also observed that those patients reported feelings of social isolation.  McGarvey and 
Hart (2008) surveyed over 200 general practitioners in Ireland; they found that 72% of 
GPs agreed that having a rare disorder gives rise to additional family problems and 28% 
felt that rare disorders can result in feelings of isolation.  No published studies have 
focused solely on the phenomenon of perceived social isolation in individuals living with 
rare diseases.   
Similar results were found when seeking to identify published studies on 
perceived social support in these conditions.  No published studies were identified that 
explored perceived social support in sarcoidosis or AATD, although Hoth and colleagues 
(2014) investigated 400 individuals with AATD and found that participation in support 
groups was associated with less ambiguity surrounding the disease.  A statistically 
significant impact on ambiguity was found in those individuals who attended three or 
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more support groups in the prior year compared with individuals who reported no such 
participation (b=−3.31, SE=1.29, p=0.010) 
4. DESIGN AND METHOD 
Both the exploration of the concept of social isolation via dimensional concept 
analysis, as well as the integrative review of instruments to measure the concept provided 
a framework from which to design the dissertation study.  The parallel convergent mixed-
methods design of the study was informed by Creswell & Plano Clark (2011). A 
quantitative descriptive approach required participants’ completion of the Friendship 
Scale (Hawthorne, 2006), a six-item Guttman scale that measures social isolation and the 
Medical Outcomes Study: Social Support Survey (MOS-SSS), a 19-item version 
instrument that measures perceived availability of social support.   Semi-structured, 
individual interviews were conducted to describe individuals’ perceptions and 
experiences of social support, relationships with others, and preferences for support 
strategies. This descriptive approach provided for a comprehensive summary of the 
experiences of social isolation and social support in the participants’ own terms 
(Sandelowski, 2000).  A convergent design facilitated the collection, analysis and 
subsequent merging of two independent data streams in a single phase (Creswell & Plano 
Clark, 2011).  After merging, divergence, convergence and other relationships were 
explored. 
5. KEY CONCEPTS/TERMS AND DEFINITIONS 
 There are two main concepts explored in this dissertation that merit presentation 
as a component of the dissertation introduction, social isolation and social support. 
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5.1. Social Isolation   
There have been many attempts to operationalize a working definition of social 
isolation.  The concept of social isolation was first discussed at length in the literature in 
the 1970s and 1980s.  Despite this rather lengthy history, social isolation continues to be 
defined inconsistently and/or used as an adjective describing very low levels of social 
support, or limited or lacking social networks (Nicholson, 2009).  Warren (1993) offered 
four criteria as defining characteristics of the phenomena.  The first, stigmatized 
environment, implies that a person has been designated as different from other persons, 
they perceive this difference and they are hesitant, unwilling, or do not know how to 
participate in social interactions with others.  This same characteristic was also noted by 
Joachim and Acorn (2003) in their focus group interviews conducted with individuals 
suffering from the rare disease of scleroderma.  The second criterion is that of societal 
indifference, where the person perceives that they are lonely, and they lack enduring or 
meaningful relationships with others.  The third criterion has to do with personal-societal 
disconnection, which implies that society rejects and alienates the stigmatized person by 
denying them access to satisfying social situations and interactions.  Last is the criterion 
of personal powerlessness where the stigmatized person buys into their own perception 
that society has rejected them; they feel as if they have no control and others possess all 
control. 
 The results of the dimensional analysis conducted as a component of this 
dissertation suggest that there are multiple factors related to the concept of social 
isolation.  Using Schatzman’s approach, the dimensions of perspective, context, 
condition, process and consequences were explored as they relate to this concept.  The 
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first, perspective, is that of limited or low social networks as well as the lack of personal 
relationships and is the central organizing standpoint of individuals experiencing 
perceived social isolation.  The second component, that of context, suggests that the 
condition occurs most often in community-dwelling older adults.  The conditions that 
often foster social isolation are that of a stigmatized environment as well as the disease 
condition.  The processes that can affect social isolation are peer counseling, support 
groups, enhancement of family networks, or internet-based support (Biordi & Nicholson, 
2009; Cudney, Butler, Weinert, & Sullivan, 2002, Holley, 2007; Weinert, Cudney, & 
Hill, 2008).  These findings are congruous with Nicholson’s (2009) proposed definition 
of social isolation which suggests that social isolation is a state in which the individual 
lacks a sense of belonging socially, lacks engagement with others,  and has a minimal 
number of social contacts that are deficient in fulfilling and quality relationships. In his 
concept analysis of social isolation in older adults, Nicholson (2009) suggested that 
determinants of isolation include “number of contacts, feelings of belonging, fulfilling 
relationships, engagement with others, and quality of network members” (p. 1349).  
Killeen (1998) defines social isolation using two different perspectives: “Social isolation 
with choice is aloneness, while social isolation without choice is loneliness” (p.764).  
Based on these theories, the working theoretical definition of social isolation is proposed 
as living without companionship, having low levels of social contact, little social support, 




5.2. Social Support 
Attempts at crystallizing a definition of social support in the literature are 
abundant, and yet, lack of a consensus definition prevails.  One theme, however, is 
generally consistent in that the construct has been studied primarily from three 
perspectives: network structure, support functions and the nature of relationships.  Social 
support has been defined and measured in various ways (Broadhead et al.1983, 
Schwarzer & Knoll 2007).  However, most definitions of social support refer in some 
context to Cobb’s seminal publication and resulting definition of social support as “the 
individual belief that one is cared for and loved, esteemed and valued, and belongs to a 
network of communication and mutual obligations” (Cobb, 1976, p. 300).  The chosen 
instrument, the MOS-SSS reflects these components by its separation and measurement 
of the domains of emotional/informational support, tangible support, affectionate support, 
and positive social interaction. Strategies to ameliorate perceptions of social isolation 
include various types of social support.  The need for the assessment and interventions to 
address social support needs of individuals with rare conditions is illustrated by the 
European Union Committee of Experts on Rare Diseases (EUCERD) in their 
investigation into the social support needs of individuals with rare diseases (EUCERD & 
Diseases, 2012).  While the goal of this study is not to investigate the effect of 
interventions, the assessment of the perceptions of social support is important to consider.  
6. THEORETICAL FRAMEWORK 
 The social network theory proposed by Heaney and Israel (2008) is one that is 
most applicable to this work.  The model depicts social networks and social support as 
the starting point or initiator of a causal flow toward health outcomes.  The depiction of 
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this model provides a succinct illustration of how social support and social networks are 
intertwined.   
 
Figure 1:  Conceptual Model for the Relationship of Social Networks and Social Support to Health 
 
 
As suggested by Heaney and Israel (2008, p. 189), an understanding of the impact 
of social relationships on health status, health behaviors, and health decision making can 
contribute to the design of effective interventions for promoting health.  In the case of 
rare diseases, community empowerment is evident in the alpha-1 population, and less so 
(in an organized fashion) in the sarcoidosis population.  As illustrated in Figure 1, 
Pathway 1 denotes the direct effect of social networks and social support on health. By 
meeting human needs for companionship, a sense of belonging, and reassurance of one’s 
worth as a person, supportive ties may enhance well-being and health, regardless of stress 
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levels (Berkman and Glass, 2000).  This was also observed in the work of Brummett et al 
(2001), Berkman and Syme (1979) and House and colleagues (1988).  Pathways 2 and 4 
represent the effect of social networks and social support on individual coping resources 
and community resources, respectively. Pathway 3 suggests that social networks and 
social support may influence the frequency and duration of exposure to stressors.  
Pathway 5 reflects the potential effects of social networks and social support on health 
behaviors.  Through social support and such networks, healthy behaviors, adherence to 
prescribed regimens and other health-seeking behaviors can be enhanced.  In applying 
this to the rare disease populations, it is clear that further study is needed, in order to 
draw correlations between specific behaviors and health outcomes, as well as 
identification of stressors that may be specific to these groups.  It is hoped that the results 
of this dissertation can provide a sound foundation and framework from which other 
work can flourish.  
7. BRIEF OVERVIEW OF MANUSCRIPTS 
The first manuscript of this dissertation presents a dimensional concept analysis 
of the phenomenon of social isolation (Flavin, 2015a).  A concept analysis guides 
dissection and examination of key components of the phenomenon under consideration, 
affording a multifaceted lens with which to view the attributes of the construct.  
Schatzman’s method of dimensional analysis (1991) is particularly suited to exploration 
of social isolation.  Dimensional analysis (DA) is a method focused on identifying the 
various factors that are involved with a phenomenon (Hobbs, 2009), and can be 
particularly useful when evaluating an unclear or potentially ambiguous concept (Kools, 
McCarthy, Durham, & Robrecht, 1996).  Dimensional analysis offers an approach to the 
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understanding of social isolation through its social construction and examination of 
differences across perspectives and contexts (Udlis, 2011).  Schatzman’s methodology 
directed the investigator to explore the dimensions of perspective, context, condition, 
process and consequences as they relate to social isolation and categorized according to 
best fit.  By definition, the central theme of social isolation was the perception of having 
limited or low social networks as well a lack of personal relationships.  The results of the 
concept analysis as a whole are presented in the published manuscript entitled “Social 
Isolation and its Applicability to Persons with Sarcoidosis and Alpha-1 Antitrypsin 
Deficiency: A Dimensional Concept Analysis” (Flavin, 2015a). The results of the 
dimensional analysis provided a more robust understanding of the various components 
that contribute to the phenomenon of social isolation.   
The second manuscript of this dissertation presents the results of an integrative 
review of the various instruments available to measure social isolation.  This paper, 
entitled “Measurements of social isolation and social support for rare lung disease 
patients: An integrative review” (Flavin, 2015b) presented the results of a review of eight 
instruments that purported to measure the construct of social isolation.  From that review, 
the Friendship Scale and the UCLA Loneliness Scale were identified as those instruments 
with acceptable psychometrics and that would be suitable for pilot use in the populations 
of interest. 
 The third manuscript of the dissertation presents the results of the pilot study, 
which used a mixed-methods approach to explore the perceptions of social isolation and 
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Objective: This parallel, convergent mixed-methods study aimed to explore the 
perceptions of social isolation and social support in individuals living with alpha-1 
antitrypsin deficiency or sarcoidosis.   
Methods:  244 participants completed a series of online questionnaires, including the 
Friendship Scale and the Medical Outcomes Study – SocialSupport Survey (MOS-SSS).  
29 individuals participated in qualitative interviews.  Logistic regression was conducted 
to explore whether any of the  clinical or demographic characteristics were predictive of 
higher/lower social isolation or social support scores. Qualitative content analysis was 
conducted to identify themes.  Results of the analyses of the two data sets were 
triangulated to provide a rich portrait of social isolation and social support as experienced 
by these individuals.   
Results:  There were significant differences in the Friendship Scale, MOS-SSS emotional 
support, positive social interaction and total scores between the alpha-1 and sarcoidosis 
groups, with higher scores observed in those with alpha-1 (indicating more social 
connectedness and perceived support).  Sarcoidosis- affected individuals who participated 
in support groups reported more social isolation as reflected in the ranks for Friendship 
Scale scores than those who did not participate in support groups (p=0.04).  Content 
analysis revealed six themes:  Self-reflection, building connections, activities, 
knowledge, relationships and physical/psychological impact.  Triangulation revealed that 






Conclusion:  Less perceived social isolation and more perceived social support were 
reported in the alpha-1 population compared with the sarcoidosis population.  Social 







In recent years, focus on rare diseases has been increasing.  An estimated 30 
million Americans live with a diagnosis of one of the 6,000 to 8,000 known rare diseases 
[1] and such conditions affect approximately 30 million individuals in the European 
Union [2]. Two of these conditions – sarcoidosis and alpha-1 antitrypsin deficiency 
(AATD) – most often affect the lungs, although other organ involvement occurs.   
Sarcoidosis is a chronic, progressive, multisystem granulomatous disease of 
unknown etiology [3] for which there is no known cure.  The clinical presentation of 
sarcoidosis varies and is dependent upon organ and system involvement.  Some 
individuals present with no physical symptoms, while others may have severe 
breathlessness (those with pulmonary involvement), tumor-like growths on the skin or 
face (skin sarcoidosis or lupus pernio), or uveitis (ocular involvement).  The incidence 
and prevalence of sarcoidosis varies worldwide, although regional variations exist.  In the 
U.S., sarcoidosis is more common in African Americans, with incidence rates as high as 
40 per 100 000/year, compared to Whites with an incidence rates range of 5–11 per 100 
000/year [4].  
AATD is a rare inherited disorder that causes lung and liver disease due to 
mutations in the gene SERPINA1, which codes for alpha-1 antitrypsin (AAT).  The 
clinical presentation of AATD can vary, and is dependent upon a variety of factors, 
including genotype.  The genetic deficiency predisposes individuals to early-onset 
emphysema, one of the phenotypes of COPD [5], although chronic bronchitis and asthma 
can also occur.  AATD is a metabolic-genetic disease that, in its classical and most 





inhibitor (PI) “Pi*ZZ” genotypes, occur in 1 in 2000 to 3500 births in North American 
and European populations [6].  In the United States, prevalence estimates suggest that 
there are between 70,000–100,000 AAT-deficient individuals, although only 10% have 
been identified [7].   
Rare diseases are often chronic, complex and associated with physical, intellectual 
or neurological disabilities that may inhibit participation in life activities, thus creating 
risk for isolation [8]. Yet, few published studies have explored the experiences of living 
with a rare disease. Studies investigating the perspective of individuals living with 
scleroderma identified persistent themes of stigma and isolation [9], although this disease 
is characterized by skin disease obvious to others.  Henderson et al. [10] investigated the 
general psychosocial impact of living with Niemann Pick disease Type B, a rare 
lysosomal storage disorder, and observed that those patients reported feelings of social 
isolation. A survey of over 200 general practitioners (GP) in Ireland revealed that 28% 
perceived that rare disorders can result in feelings of isolation [11].  Whether diseases 
that have no obvious outward signs impact feelings of isolation remains unstudied.  
Social isolation is defined as "a state in which the individual lacks a sense of 
belonging socially, lacks engagement with others, has a minimal number of social 
contacts and where the individual is deficient in fulfilling and quality relationships" [12].  
Over the past three decades, studies have shown social isolation to be predictive of 
mortality and morbidity in the general population [13, 14, 15] and in populations with 
chronic conditions [16, 17]. Despite the high number of individuals affected by rare 





get the information and support needed [18]. To date, no studies have specifically 
explored social isolation in rare lung diseases such as AATD or sarcoidosis.  
Although recognition of the importance of research into rare lung diseases has 
been growing [19], this focus has been primarily from the biomedical perspective, with 
less attention given to the psychosocial aspects. To address this gap in rare disease 
research, the overall objective of our study was to gain insight into perceptions and 
consequences of social isolation and social support as experienced by individuals with 
AATD and sarcoidosis.  In addition, we sought to gain preliminary understanding of the 
effects of participation in support groups in these individuals.   The overarching question 
driving this mixed methods study was:  How do individuals with the rare lung diseases of 
AATD and sarcoidosis perceive and describe the social impact and consequences of 
living with these diseases?  
Methods 
Design 
We applied a parallel convergent mixed-methods design to explore perceptions of 
the social impact of living with one of two rare diseases. This design facilitated the 
collection and analysis of two independent data streams, one quantitative and one 
qualitative, simultaneously with subsequent comparison and merging of findings to 
develop a more complete understanding of the social impact of rare lung disease [20].  
Participants  
Our goal was to recruit an equal distribution of AATD and sarcoidosis 
participants. Individuals with AATD were recruited through the Alpha-1 Foundation 





participants were recruited through snowball sampling beginning with individual 
participants of a sarcoidosis support group familiar to the PI.  To be eligible, individuals 
were required to be adults who self-reported a physician diagnosis of AATD or 
sarcoidosis with pulmonary involvement, and confirmed their ability to read and speak 
English.  There was no specific timeframe required for diagnosis.  Individuals were 
required to have access to a computer with a valid email address (for purposes of 
completing instruments via the Research Electronic Data Capture REDCap survey site).  
Data Collection 
Participants completed online surveys of validated measures of social isolation 
and social support through using (REDCap), an electronic web-based data collection 
system [21].  We randomly selected a subgroup of participants who consented to take 
part in subsequent qualitative interviews to obtain rich data on perceptions of social 
support and relationships with others.  A qualitative descriptive approach guided the 
interviews to gain a description of social isolation and associated consequences in 
everyday terms from the participants [22]. 
Measures 
Demographics and Clinical Characteristics. We collected general demographic 
information as well as years since diagnosis, disease condition (sarcoidosis or AATD), 
genotype (AATD), disease severity (sarcoidosis), presence of pain or fatigue, frequency 
of leaving the home within the prior week, participation in support or advocacy groups 
and participation in outside activities. 
Pulmonary status. Due to the pulmonary involvement associated with these diseases, we 





Medical Research Council (mMRC) Dyspnea Score was used to assess the severity of 
perceived breathlessness on a five-point scale (0-4) [23].   
Social Isolation. The Friendship Scale [24] is a six-item Guttman scale that measures 
perceived social isolation.  The scale assesses both critical aspects of social isolation: 
perceived social isolation (3 items) and perceived emotional loneliness (3 items). Scores 
for each item range from zero to 4 with a total score ranging from zero to 24. Cutpoints to 
classify levels of social isolation range from 0-11 (very socially isolated) to 22-24 (very 
or highly socially connected) [24]. The psychometric properties of the scale in the 
validation study conducted in older adult populations in various types of settings suggest 
excellent internal structures as assessed by structural equation modeling (CFI = 0.99, 
RMSEA = 0.02), reliability (Cronbach’s alpha = 0.83), and discrimination when assessed 
against two other short social relationship scales [24, 25, 26].   A subsequent validation 
study in individuals with low back pain showed similar results [25].  Tests of concurrent 
discriminant validity suggest it is sensitive to the known correlates of social isolation 
[24].   
Social Support. We evaluated perceived social support using the Medical Outcomes 
Study: Social Support Survey (MOS-SSS). The scale is a 19-item instrument containing 
four domains to assess perceived availability of social support, including (1) emotional/ 
informational support, (2) tangible support, (3) positive social interaction and (4) 
affectionate support [27].  Responses are scored via a 5-point Likert-type scale, and range 
from “none of the time” to “all of the time”.  Scores range from 0-100 with higher scores 
indicating more perceived support.  Sound psychometrics of the MOS-SSS were 





Cronbach’s alpha  ranging from 0.91 to 0.97 for the various subscales and high 
convergent and discriminant validity of items.  Subsequent and supportive validation 
studies were also conducted with Chinese [28], Portuguese [29] and Black individuals 
[30]. 
Qualitative Interviews 
 Interviews took place via telephone. An interview script comprised of eight questions 
was used to facilitate approximately 60-90 minutes of dialogue, although modified where 
appropriate.  
• I’d like to start by having you describe a typical day 
• Can you tell me a little bit about how having <<alpha-1/sarcoidosis>> has affected your 
life? What place does it have in your life? 
• How have people in your life reacted to your having <<alpha-1/sarcoidosis>>? 
• Can you tell me a little bit about how having <<alpha-1/sarcoidosis>> has affected your 
relationships with other people? 
• Can you tell me what happens if you ask others for help?   
• Tell me a bit how you access support for your condition 
• What do you do for enjoyment? 
• Can you tell me a little bit about why you chose to participate in this study?    
 
Semi-structured questions and prompts were used to yield narratives centering on social isolation 
and/or social support.  All interviews were audio recorded and transcribed. 
Statistical and qualitative analysis 
During the quantitative data analysis, data were exported from the REDCap 
database to SPSS v22 [31] for analysis.  The primary analysis used all available data from 
all subjects who attempted completion of the questionnaires. Any respondents missing an 
item were excluded only from tests involving that item. 
Descriptive statistics were computed on the demographic and clinical 
characteristics of the study population.   For categorical and ordinal variables frequencies 





including mean, median and standard deviation were calculated.  All continuous variables 
were assessed for normality and all distributions of variables were skewed except age; 
therefore, appropriate non-parametric analysis methods were used.  For age, the two 
groups were compared using the independent samples t-test; other continuous variables 
were compared using the Mann-Whitney U-test. 
Mean total scores (with 95% CIs) and median scores were calculated for the 
pooled study population and individual disease groups, for both the Friendship Scale and 
MOS-SSS. The average Friendship Scale and MOS-SSS scores are broken down by 
condition in the table below and the ranks compared using the Mann-Whitney-U test 
(Wilcoxon rank-sum test). To assess the effect of support group participation, the pooled 
study population was dichotomized into individuals who reported participating in online 
or face-to-face support groups and those who reported not participating in such groups.  
Non-parametric Mann-Whitney test was utilized to compare the two groups.  
Logistic regression was conducted to explore whether any of the demographic or 
clinical characteristics might be predictive of higher/lower social isolation or social 
support scores. The Friendship scale was dichotomized into those who were very 
isolated, isolated, and with some isolation [range of scores 0-18] versus the socially 
connected and very socially connected (range of scores 19-24)[25].  The MOS-SSS was 
dichotomized to indicate those who perceived low-normal social support (below 75th 
percentile; scores ≤ 85.5) or high social support (above or equal to the 75th percentile; 
scores >85.5) [32].  Predictor variables were entered individually, and the individual 





Qualitative analyses of interview data were conducted using NVivo10 qualitative 
software [33] and directed content analysis [34, 22].   Each interview was transcribed 
after the completion of the interview and the transcript was reviewed in conjunction with 
the audio recording. The investigator read the transcripts and used an initial coding 
approach to abstract passages in an exploratory manner.  Interview transcripts were coded 
line-by-line and themes and subthemes developed [35].  After initial themes were 
identified, additional data abstraction occurred, including compression of themes [36] and 
review by an expert qualitative nurse scientist for confirmation of themes.   
Quantitative and qualitative findings were merged to create a robust preliminary 
profile of individuals’ perceptions of social isolation and social support.  After merging 
the two data streams, divergence, convergence and other relationships were explored 
[20]. 
Ethics approval 
Institutional Review Board (IRB) approval was obtained at the Medical 
University of South Carolina.  The study was approved for a waiver of signed consent 
and participants were provided with a Statement of Research upon accessing the online 
survey. All data were cleaned of any potentially identifying information to maintain 
participant anonymity and confidentiality. 
Results 
 Sample  
 A total of 244 participants completed the online questionnaire, 177 with AATD 
and 67 with sarcoidosis. For the sarcoidosis population, 75 participants were contacted 





population, a total of 1125 potential participants were contacted in two separate email 
“blasts” by the Alpha-1 Registry coordinator, (562 participants in the first email, 
followed by 563 different participants in the second email). Of those, 177 subjects 
completed the online questionnaires. The initial goal of an equitable distribution of 
AATD and sarcoidosis participants was not achieved due to the limited access to and 
response of sarcoidosis patients in comparison with the AATD group, and was likely 
skewed due to the access facilitated by the AATD registry coordinator. 
For the qualitative phase of the study, subjects responded to a single question at 
the end of the online questionnaire indicating their willingness to participate in an 
interview. Eighty four percent (205/244) of the subjects who participated in the 
questionnaire completion agreed to participate in the interviews; of those, twenty-nine 
(15=AATD, 14=sarcoidosis) were randomly selected to complete semi-structured, 
individual interviews.  
  AATD subjects were statistically significantly older (59.4 (SD=11.4) than 
sarcoidosis participants (50.1 (SD=8.3), p<0.0001).  There were was a significant 
difference in the gender make-up of the two populations:  there was a larger proportion of 
males in the AATD group (37.4%) than in the sarcoidosis group (16.4%), while there was 
a smaller proportion of females in the AATD (62.6%) group compared to the sarcoidosis 
group (83.6%) (p=0.002).   
Overall, the study population was primarily female (n=165, 68.5% of all participants).  
Pi*ZZ was the most common genotype for alpha-1 participants (97; 55.7%), followed by 
MZ (32; 18.4%).  Most sarcoidosis participants did not know the stage of their disease 





or 4 disease (9, 13.8% for each stage). The majority of subjects in both populations were 
married.  More subjects in the alpha-1 population (93; 53.4%) lived with a spouse or 
partner than in the sarcoidosis population (24; 35.8, %, p=0.003).  The vast majority was 
white and less than 6% of the population self-reported as Hispanic.  Annual household 
income ranged from $25,000 to $99,000.  Additional details are reported in Table 1. 
More alpha-1 individuals participated in face-to-face support groups (26.3% vs. 13.6%, 







Table 1  Demographic and clinical characteristics overall and by disease 








Age, mean (SD) 56.6	  (11.4)	   59.4	  (11.4)	   50.1	  (8.3)	   *<0.001	  
Gender     
     Male 76(31.5)	   65(37.4)	   11(16.4)	   *0.002	  
     Female 165(68.5)	   109(62.6)	   56(83.6)	   	  
Marital status, n(%)     
     Married 154(64.7)	   113(65.7)	   41(62.1)	   0.31	  
     Single 17(7.1)	   12(7.0)	   5(7.6)	   	  
     Divorced 43(18.1)	   27(15.7)	   16(24.2)	   	  
     Widowed 7(2.9)	   7(4.1)	   0	   	  
     Partnered 17(7.1)	   13(7.6)	   4(6.1)	   	  
Living situation     
     Alone 39(16.2)	   32(18.4)	   7(10.4)	   *0.003	  
     With spouse/life partner 117(48.5)	   93(53.4)	   24(35.8)	   	  
     With children 16(6.6)	   7(4.0)	   9(13.4)	   	  
     With spouse/life partner & children 54(22.4)	   33(19.0)	   21(31.3)	   	  
     With a friend 5(2.1)	   2(1.1)	   3(4.5)	   	  
     Other  10(4.1)	   7(4.0)	   3(4.5)	   	  
Race     
   White 226(93.0)	   173(98.3)	   53(79.1)	   <0.001	  
   Black or African American  11(4.5)	   1(0.6)	   10(14.9)	   	  
   American Indian or Alaska Native 1(0.4)	   0	   1(1.5)	   	  
   Asian Indian 1(0.4)	   0	   1(1.5)	   	  
   Other 4(1.6)	   1(0.6)	   3(4.5)	   	  
Annual household income (per year)     
   <$10,000 15(6.8) 10(6.1) 5(8.6) 0.82 
   $10,000-$24,999 34(15.4) 24(14.7) 10(17.2)  
   $25,000-$49,999 58(26.2) 42(25.8) 16(27.6)  
   $50,000-$99,999 81(36.7) 63(38.7) 18(31.0)  
   $100,000+ 33(14.9) 24(14.7) 9(15.5)  
MRC	  Dyspnea	  Score,	  n	  (%)	   	   	   	   	  
	  	  	  	  	  	  	  	  	  	  	  	  0	   27(11.3)	   19(10.9)	   8(12.3)	   0.63	  
	  	  	  	  	  	  	  	  	  	  	  	  1	   82(34.2)	   64(36.6)	   18(27.7)	   	  
	  	  	  	  	  	  	  	  	  	  	  	  2	   97(40.4)	   66(37.7)	   31(47.7)	   	  
	  	  	  	  	  	  	  	  	  	  	  	  3	   26(10.8)	   20(11.4)	   6(9.2)	   	  
	  	  	  	  	  	  	  	  	  	  	  	  4	   8(3.3)	   6(3.4)	   2(3.1)	   	  
Participates	  in	  face	  to	  face	  support	  groups,	  
n	  (%)	  
55(22.8)	   46(26.3)	   9(13.6)	   *0.04	  
Participates	  in	  online	  support	  groups,	  n	  
(%)	  
107(44.4)	   49(28.0)	   58(87.9)	   *<0.001	  
Participates	  in	  advocacy	  groups	   56(23.2)	   41(23.3)	   15(23.1)	   0.97	  






Social isolation and social support scores 
There were statistically significant differences in the Friendship Scale, MOS-SSS 
emotional support positive social interaction domains and MOS-SSS total scores between 
the two groups, with higher scores observed in those with alpha-1 (indicating more social 
connectedness and perceived support).  Although not statistically significant, the other 
domain scores of the MOS-SSS (tangible support and affectionate support) were also 
slightly higher in the AATD group.  A comprehensive overview of scores is provided in 
Table 2. 
Table 2:  Average Friendship Scale and Medical Outcomes Scale – Social Support Survey (MOS-SSS) by Study 



















   




















































































(35.2-75.0) 5975.0 -2.481 *0.01 
*Statistically significant at the 0.05 level 
 
Support Group participation 
As illustrated in Table 3, no differences in ranks were observed for either 
instrument scores for the overall population in terms of who had participated in support 
groups compared to those who had not participated in support groups.  This applied to the 





participants had lower Friendship Scale scores (and thus, were more isolated) compared 
to those who did not participate in support groups (with higher scores indicating more 
isolation).   
Table 3:  Friendship Scale and Medical Outcomes Scale – Social Support Survey (MOS-SSS) by Study 
Population and Condition by Access to Support 
 Accessed support Did not access support W Z p-value 








   
All respondents        
Total, N 134  108     








15256.5 -1.211 0.22 










13930.5 -0.635 0.53 
Alpha-1        
Total, N 75  100     








8153.5 -0.734 0.46 










7319.0 -0.754 0.45 
Sarcoidosis        
Total, N 59  8     








1836.5 -2.096 *0.04 










1679.5 -1.18 0.24 
* Statistically significant at the 0.05 level 
 
Predictors of isolation and support 
As illustrated in Table 4 and Table 5 in the Appendix, and using the isolation cut 
points described previously, females had twice the odds of males to report perceptions of 
social isolation (OR=2.10; p=0.01, 95%CI [1.21, 3.66]), and single and divorced persons 
had almost 4 times the odds of married individuals to report isolation (OR=3.66 and 3.72; 
p=0.03 and 0.001, 95% CI [1.14, 11.74] and [1.71, 8.08] ,respectively).  Individuals who 
lived alone were also twice as likely to report feeling isolated (OR=2.30; p=0.03, 95% CI 
[1.09, 4.88]).  Those with more severe breathlessness, as indicated by the MRC Dyspnea 
scale score of 3 or 4 (OR=3.58; p=0.03, 95% CI [1.17, 11.01]), or those with more severe 





more likely to report feelings of isolation.  Individuals with visual impairments had 
higher odds of reporting isolation than those who did not have such sight impairments 
(OR=2.99; p=0.04, 95% CI [1.06, 8.38]).  Odds of reporting significant isolation were 
higher for persons who reported difficulties with activities of daily living such as 
concentrating (OR=7.28; p<0.001, 95% CI [3.57, 14.86]), walking up stairs (OR=3.38; 
p<0.001, 95% CI[1.97, 5.83]), dressing/bathing (OR=2.73, p<0.001, 95% CI[1.48, 5.01]) 
or doing errands (OR=3.65; p<0.001, 95% CI [2.04, 6.52]) compared to their 
counterparts.  Odds of reporting significant isolation were also higher for individuals who 
reported pain within the prior 30 days (OR=1.07; p<0.001, 95% CI [1.04-1.10]) or 
fatigue within the prior 30 days (OR=1.06; p<0.001, 95% CI  [1.04, 1.09]) compared to 
their counterparts.   
The risk factors for lower social support presented in Table 6 and Table 7 
included female sex (OR=2.09; p=0.02, 95%CI [0.94, 1.00]), and living alone (OR=4.51; 
p=0.02, 95%CI[1.33, 15.34]). Also, the odds of low social support increased for single 
(OR=3.28; p=0.13, 95%CI [0.72, 15.05]), divorced (5.78, p=0.01, 95% CI [1.69, 19.75]), 
and widowed participants (OR=2.81; p =0.35, 95%CI [0.33, 24.06]) compared to married 
participants.  Medical factors associated with lower social support included an MRC 
dyspnea scale ≥3 or 4 (OR=3.97; p=0.12, 95%CI [0.69, 22.82]), difficulty concentrating 
(OR=2.75; p =0.01, 95% CI [1.26, 6.02]), any pain within the prior 30 days (OR=1.04; p 







Qualitative description of social impact of Rare Disease 
After initial coding and compression of codes from the qualitative interviews, six 
main themes related to the social impact of the disease emerged:  Self-reflection, building 
connections, activities, knowledge, relationships, and physical/psychological impact.   
Self-reflection 
The concept of self-reflection emerged as participants described becoming more 
insightful and thoughtful about the effect of having a rare disease on their lives. Six 
individuals (20.7%) described engaging in activities that facilitated self-reflection to help 
them cope, whether by meditation or verbalizing some form of gratitude as a result of 
their condition.   
Building connections  
 All of the participants (n = 29, 100%)  described “building connections” with 
others.  These connections were grouped into subcategories of altruism, volunteering, and 
a support network.  Often, the introduction to a support network was due to the 
participant’s desire for additional information after initial diagnosis, and led to the 
individual feeling a connection to the group. Such connections were often formed as a 
result of feelings of isolation.  
…support is very important; you do feel very isolated with this disease…..There is 
not a lot of medical information out there.  We certainly kick each other’s brains 
a lot; what you want, what you being treated with, how much of it they using, how 





We’re all in this together.  No matter what we do, when we do it or how we do it 
we can make a contribution, all it takes is little time, effort and caring and baby 
steps…we’re making strides and something that we’d only discovered 50 years 
ago, which is incredible.  When you look at other conditions, I think the Alpha-1 
community is so progressive in its thinking and in how it generates information 
and enthusiasm to help the little ones that are struggling with this and maybe 
we’ll see a cure in their lifetime. 
Individuals spoke of their experiences volunteering, participating in various 
support group venues, and a sense of altruism as a result of their condition.  Six 
individuals reported volunteering, and most of these activities were not related to their 
disease.  Activities included church events, free clinic work and education.  Twenty-eight 
individuals (96.6%) spoke of their experiences with a support network, (family, friends, 
organizations like the Alpha-1 network, or Facebook sites and groups).   Some 
individuals felt that the online sites were negative, with individuals using the sites to vent 
complaints. A sarcoidosis participant reported: 
I am in a Facebook group and I told my son I find when I am reading some of 
their posts I get really frustrated because they will be asking.. well, have you ever 
had this or what do you suggest to take if you have low potassium…  It's really a 
strange thing because it's constant complaining.   
Participants with sarcoidosis also often spoke of face-to-face meetings being 
widely geographically dispersed, difficult to attend, and poorly attended. As one 





I tried to occasionally attend a sarcoid support group in Portland but that is 140 
miles one way.  It’s hard to drive that far.  I do belong to Inspire Online (an 
online support group community).  I post there occasionally.  I read there.  I have 
a group that I met from there.  One of them I met face to face.  We have a group 
of seven of us and we have a little private Facebook group.  
Activities 
Participants described the impact of rare disease on their ability to engage in 
routine activities of daily living, including outside activities as well as household 
responsibilities and socialization with others.  Twenty-two individuals (75.9%) 
verbalized impact of the disease on their activities and/or lifestyle, oftentimes leading to 
feelings of isolation due to their inability to actively socialize.  Individuals described an 
intuitive sense of how to pace themselves, however:  
I do have to pace myself, I get very tired.  And I never feel good, I never ever feel 
good. 
Relationships 
Nineteen (73.1%) of the participants discussed their experiences with seeking 
help, which was often a change in established roles with family or friends.  That it, many 
moved from the “giver” role to the “recipient” role, in terms of assistance.  In general, 
many individuals were reluctant to ask for help early in the disease process. As one 
participant shared:    
I hate asking for help, I really do…My husband is a great help and my kids have 





is definitely old enough to help, but I don’t want to be that person that asks for 
help because of any issue. 
 Descriptions of relationships with children varied, with some individuals sharing 
about the positive relationships that they had with their children, despite the disease, 
while others voiced concern about the effect that the disease had on their children: 
It is really hard for her.  She remembers mom being able to do more with other 
kids.  There is a seven or eight years difference between her and my oldest.  She 
remembers me being much more active; much more able to go do things. 
Married participants spoke abundantly about the role of spousal support: 
He and I have researched and done everything we can and we still will do 
everything that we can to try to get help for this disease and that’s one thing I'm 
very fortunate that I have someone that cares that much and loves to be that 
involved with me with it. 
Physical/psychological impact  
The impact on physical or mental well-being was coded under the umbrella of 
physical or psychological impact.  In general, reports of physical impact were from those 
with sarcoidosis and specific to fatigue or pain.  In terms of psychological impact, 
acceptance was a strong and recurring theme among many individuals. Participants 
frequently reported fear at time of diagnosis.    
Individuals spoke of becoming isolated as a result of the disease.  Whether they 






I have a couple of them still call; I have some that talk to me on Facebook but for 
the most part my friends have gone because I don’t have the common things that 
we used to working together.  So, I don’t have the friendships that I used to 
have…. but for the most part I feel pretty lonely 
For some, the isolation was so pronounced that it threatened their very existence: 
Mostly there are days that are so lonely and so – just – that I have actually said to 
my physician I promise you I cannot live the rest of my life this way and I meant 
every ounce of the word. 
Merging of Data through Triangulation  
This mixed methods study was designed to elicit an understanding of the depth 
and breadth of perceptions of social isolation and social support in populations with 
sarcoidosis or alpha-1. To achieve this, the two data streams were merged via data 
triangulation.  The essence of  a triangulation approach is the ability to utilize two 
methods to conduct independent assessments of the same phenomena [37] and to then 
integrate the findings.  The integration in this study consisted of combining the narrative 
qualitative data with the numeric quantitative data. Although these two sets of analyses 
were conducted independently, the intent was that the qualitative data would provide 
depth and breadth of understanding to the findings from the quantitative data (Figure 1).  
This parallel mixed analysis resulted in a convergence (and in some cases, divergence) of 
findings that would not be apparent with a single approach.  The figure below illustrates 













Figure 1: Process of parallel mixed analysis 
 
Although there was much discussion regarding the physical aspects of the disease, 
triangulation focused on exploring the narrative comments and their confirmation with or 
contradiction to each subgroup’s mean scores of the Friendship Scale and the MOS-SSS.  
Common themes mentioned by multiple participants are listed in the qualitative portion 
of the summary table (Table 8). Merged findings are presented with quantitative scores of 
the two instruments first, followed by qualitative findings that confirm or contradict the 
quantitative scores [20]. This data merging process produced a comprehensive, albeit 
somewhat limited (due to the size and nature of the study) understanding of this 
population’s perceptions of social isolation and social support.   
Results of the triangulation analysis indicated that in general, sarcoidosis 
participants perceived lower social support, even though they participated in various 





frequently of family support.  Both groups described feeling isolated, and these feelings 
were reflected in the quantitative Friendship Scale scores.  The sarcoidosis group – which 
was more overt in their description of feeling isolated, also had lower Friendship Scale 
scores as compared to the alpha-1 group; those differences were statistically significant. 
For those participants whose direct quotes are featured in Table 3, individual scores are 
provided.  In general, when comparing individual scores on the two instruments with 
what participants stated qualitatively, there was good alignment, with the exception of 
few outlying instances 
Discussion 
Unlike previous studies of populations with rare diseases, this study explored 
similarities and differences between two groups with rare lung diseases.  It demonstrates 
successful conduct of a study in rare groups using virtual methods, which can be a viable 
option for groups that are geographically dispersed, or for the ultra-rare diseases.  Using a 
mixed methods approach, the study design facilitated the analysis of a large number of  
perspectives on the social impact of their disease, both quantitatively as well as allowing 
for a more in-depth understanding of these concerns and responses via qualitative 
interviews.  Due to the robust response of the AATD community in particular, a large 
number of participants were enrolled, increasing the power of the study to detect 
differences.   
Findings that individuals who suffer from rare diseases may experience feelings 
of social isolation and perceive a lack of social support are not unexpected.  What may 
not be apparent using one form of data collection and analysis is that these phenomena 





spur the vicious cycle of isolation.  Although individuals reported feeling supported, it is 
also evident that some of that support came from virtual communities (such as Facebook) 
with their inherent assets and shortcomings.  One obvious asset is accessibility 
irrespective of geography.  An individual can “speak” to a community without having to 
overcome transportation and distance challenges, which can be a hurdle in those with 
physical or financial constraints.  One liability that has not been discussed at length in the 
literature is that in some virtual communities, there may be an underlying sense of 
“complaining” or “disease one-upmanship”, as some individuals use the virtual boards to 
voice a litany of complaints or compare illness notes.  The most important finding in this 
study was the fact that despite the seemingly “ease of access” of virtual communities, a 
number of individuals felt that the tone of many of the groups was negative, and so they 
sought to break off and start their own closed groups.   
 There were subtle differences between the populations that became apparent 
during data analysis.  For example, although many of the AATD participants knew their 
genotype, the majority of sarcoidosis participants did not know their stage of lung 
involvement.  This may be due to the fact that in this population, staging is not discussed 
as frequently as organ involvement when individuals self-classify.  There were more 
AATD participants who reported being active in face-to-face support groups than 
sarcoidosis participants, and conversely, more sarcoidosis participants who reported 
activity in online support groups than AATD individuals.  This may be driven in part by 
the paucity of live support groups available to sarcoidosis patients, and also due to the 





The AATD population in this study scored higher on both instruments, indicating 
more perceived social support and less isolation.  These participants frequently 
mentioned the presence and impact of the Alpha-1 Foundation and its organized 
communities, whereas there was no mention of sarcoidosis organizational involvement in 
this sample of sarcoidosis patients.  In addition, as there are approved therapies for alpha-
1 (Alpha-1 Protease Inhibitor, A1PI), individuals who are managed with this therapy also 
are assigned to an Alpha-Net coordinator (who also has the condition) who facilitates 
care, and often acts as a de facto support person. Among participants, these coordinators 
often took the place of support group(s), and were spoken of very highly during the 
interviews.  In general, there were few divergent findings.  Both groups reported some 
measure of social support, and some social isolation; much of the qualitative data were 
convergent with the instrument scores.  
The implications of these findings suggest that support groups and support 
persons can be effective in enhancing the lives of individuals with rare diseases.  Future 
research should examine the similarities and differences of both live and virtual support 
groups, and explore structured and unstructured formats for both populations.  A more 
structured, facilitated sarcoidosis support group could provide additional data to inform 
tailoring of future support groups for both populations and recommendations for 
facilitating support groups.  
Limitations 
 There were a number of limitations inherent in the study.  All participants were 
recruited virtually; the results may not be representative of individuals who tend to be 





virtually, the two populations were accessed using different approaches.  The AATD 
participants were part of the MUSC Alpha-1 registry, and by nature, had already 
consented to the idea of participating in research.  There was likely some degree of 
relationship with the coordinator and/or investigator and so there may have been some 
bias in terms of their willingness to participate in this study.  The sarcoidosis participants 
were contacted via convenience or snowball sampling, and were generally not part of an 
established unit, such as the MUSC Alpha-1 Registry.   However, by virtue of knowing 
an individual who was sharing information about the study, some measure of community 
bias could have been present.  All participants were located in the U.S., and per the study 
protocol, were required to have computer access in order to complete the survey; this 
may limit the generalizability of the findings.  Limitations related to lack of computer 
access cannot be dismissed, and the effects of the digital divide still exist.  Kontos and 
colleagues [38] found that in the U.S, lower socioeconomic status, older, and male adults 
were less likely to engage in a number of eHealth activities compared to their 
counterparts.  In the U.S., sarcoidosis disproportionately affects African-Americans [39], 
who often face other economic challenges.  Challenges with enrollment were also noted 
in a recent web-based survey of sarcoidosis patients including limited access to the 
internet, failure to complete surveys, disengagement from healthcare providers and 
concerns about protection of personal information [40].  
Although no participants voiced concerns about the instruments chosen to 
measure social isolation or social support, and there was very little missing data, the 
method of dichotomizing the scales to measure isolation and social support may have 





However, as this was a pilot study and we sought to mirror previous approaches using 
categorical variables, we chose to follow precedent, rather than revert to using continuous 
measures.   
Conclusion 
 This population of individuals with AATD or sarcoidosis reported significant 
disease-related concerns, and the majority utilized some form of support group or person.  
Often, support-seeking was prompted by the individual seeking information.  The use of 
virtual communities was a common theme, although many of these communities were 
criticized by the very individuals they sought to serve because of the tone of negativity 
that occasionally, permeated the discussion threads.  It may be that such communities 
would benefit from the oversight of a facilitator not unlike the established Alpha-Net 
coordinator, although issues and challenges of trust also accompany that potential 
solution.  The ability to measure patient concerns quantitatively, along with enhancing 
that information with subjective comments garnered through interviews may help in 
crafting future interventions to facilitate support in these populations, as well as other rare 
groups.  Future research should further examine the phenomena of social isolation and 
social support in larger studies and also include other hypothesized predictors of these 
feelings.   
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(Intended for use as online supplementary material) 
 
As illustrated in Table 4, females had twice the odds of males to report 
perceptions of social isolation (OR=2.10; p=0.01, 95%CI [1.21, 3.66]), and single and 
divorced persons had almost 4 times (OR=3.66 and 3.72; p=0.03 and 0.001, 95% CI 
[1.14, 11.74] and [1.71, 8.08] ,respectively) the odds of married individuals to report 
isolation (OR=3.66 and 3.72; p=0.03 and 0.001, 95% CI [1.14, 11.74] and [1.71, 8.08] 
,respectively).  Individuals who lived alone were also twice as likely to report feeling 
isolated (OR=2.30; p=0.03, 95% CI [1.09, 4.88]).   
 




OR 95% CI Wald df p-value 
Age  0.96 0.94-0.99 8.37 1 *0.004 
Gender       
   Male** 33(43.4) 1  6.92 1 *0.01 
   Female 100(61.7) 2.10 1.21-3.66    
Marital Status       
   Married** 71(47.0) 1  14.66 4 *0.01 
   Single  13(76.5) 3.66 1.14-11.74   *0.03 
   Divorced 33(76.7) 3.72 1.71-8.08   *0.001 
   Widowed 3(42.9) 0.85 0.18-3.91   0.83 
   Partnered 9(52.9) 1.27 0.46-3.46   0.64 
Living situation       
   Not alone** 105(52.5) 1  4.75 1 *0.03 
   Alone 28(71.8) 2.30 1.09-4.88    
Annual household income 
(per year) 
      
   <$10,000** 11(78.6) 1  19.25 4 *0.001 
   $10,000-$24,999 27(79.4) 1.05 0.23-4.83   0.95 
   $25,000-$49,999 38(65.5) 0.52 0.13-2.07   0.35 
   $50,000-$99,999 34(42.5) 0.20 0.05-0.78   *0.02 
   $100,000+ 14(43.8) 0.21 0.05-0.91   *0.04 
Ethnicity       
    Hispanic, Latino/a or 
Spanish origin** 
7(53.8) 1  0.01 1 0.72 
    Not of Hispanic, Latino/a 
or Spanish origin 
124(55.4) 1.06 0.35-3.26    
Race       
   White** 123(55.2) 1     
   Non-white 9(60.0) 1.22 0.42-3.542 0.13 1 0.65 









As illustrated in Table 5, individuals who self-reported more severe 
breathlessness, as indicated by the MRC Dyspnea scale score of 3 or 4 (OR=3.58; 
p=0.03, 95% CI [1.17, 11.01]), or those with more severe sarcoidosis staging of Stage 3 
or 4 (OR=7.78; p=0.03, 95% CI [1.17, 51.92]) were also more likely to report feelings of 
isolation.  
Individuals with visual impairments (OR=2.99; p=0.04, 95% CI [1.06, 8.38]) had 
higher odds of reporting isolation than those who did not have such sight impairments 
(OR=2.99; p=0.04, 95% CI [1.06, 8.38]).  Odds of reporting significant isolation were 
higher for persons who reported difficulties with activities of daily living such as 
concentrating (OR=7.28; p<0.001, 95% CI [3.57, 14.86]), walking up stairs (OR=3.38; 
p<0.001, 95% CI[1.97, 5.83]), dressing/bathing (OR=2.73, p<0.001, 95% CI[1.48, 5.01]) 
or doing errands (OR=3.65; p<0.001, 95% CI [2.04, 6.52]) also had higher odds of 
reporting significant isolation compared to their counterparts.  Odds of reporting 
significant isolation were also higher for individuals who reported pain within the prior 
30 days (OR=1.07; p<0.001, 95% CI [1.04-1.10]) or fatigue within the prior 30 days 
(OR=1.06; p<0.001, 95% CI  [1.04, 1.09]) had higher odds of reporting significant 







Table 5: Associations between Clinical Characteristics and Perceived Isolation 
 Isolated, n(%) OR 95% CI Wald df p-value 
Condition       
   Alpha-1** 90(52.0) 1  3.30 1 0.07 
   Sarcoidosis 43(65.2) 1.72 0.96-3.10    
Genotype       
   ZZ** 49(51.6) 1  2.03 3 0.57 
   SZ 9(50.0) 0.94 0.34-2.57   0.90 
   MZ 19(59.4) 1.37 0.61-3.09   0.45 
   MS/SS/Other 6(37.5) 0.56 0.19-1.67   0.30 
Severity       
   Stage 1 or 2** 3(37.5) 1  4.49 1 *0.03 
   Stage 3 or 4 14(82.4) 7.78 1.17-51.92    
MRC Dyspnea Score       
   0** 14(51.9) 1  11.16 3 *0.01 
   1 34(44.4) 0.74 0.31-1.78   0.50 
   2 54(57.4) 1.25 0.53-2.96   0.61 
   3 or 4 27(79.4) 3.58 1.17-11.01   *0.03 
Blind or serious difficulty seeing       
   No** 115(53.2) 1  4.31 1 *0.04 
   Yes 17(77.3) 2.99 1.06-8.38    
Difficulty concentrating, 
remembering or making 
decisions, 
      
   No** 70(42.4) 1  29.7 1 *<0.001 
   Yes 59(84.3) 7.28 3.57-14.86    
Difficulty walking or climbing 
stairs 
      
   No** 35(37.6) 1  19.33 1 *<0.001 
   Yes 98(67.1) 3.38 1.97-5.83    
Difficulty dressing or bathing       
   No** 83(49.1) 1  10.45 1 *0.001 
   Yes 50(72.5) 2.73 1.48-5.01    
Difficulty doing errands alone       
   No** 68(44.7) 1  19.17 1 *<0.001 
   Yes 65(75.7) 3.65 2.04-6.52    
Number days (in past 30) pain 
made usual activities hard 
 1.07 1.04-1.10 23.6 1 *<0.001 
Number days (in past 30) fatigue 
made usual activities hard 
 1.06 1.04-1.09 27.12 1 *<0.001 
Number days (in past 7) left 
house or apartment  
 0.92 0.87-0.96 12.03 1 *0.001 
Participates in online support 
groups 
      
   No** 71(54.2) 1  0.27 1 0.61 
   Yes 61(57.5) 1.15 0.68-1.92    
Participates in face to face 
support groups 
      
   No** 107(58.8) 1  3.01 1 0.08 
   Yes 25(45.5) 0.58 0.32-1.07    
Participates in advocacy groups       
   No** 103(56.9) 1  0.82 1 0.36 
   Yes 28(50.0) 0.757 0.42-1.38    
Participates in Groups/activities 
participated in outside the home 
      
   No** 55(76.4) 1  16.88 1 *<0.001 
   Yes 78(46.7) 0.271 0.15-0.51    







As illustrated in Table 6, females again had twice the odds of reporting low-
normal social support (OR=2.09; p=0.02, 95%CI [0.94, 1.00]).  Those who lived alone 
had over four times the odds of reporting low to normal social support (OR=4.51; p=0.02, 
95%CI[1.33, 15.34]). Also, the odds of low social support increased for being single 
(OR=3.28; p=0.13, 95%CI [0.72, 15.05]), being divorced (5.78, p=0.01, 95% CI [1.69, 
19.75]), and being widowed participants (OR=2.81; p =0.35, 95%CI [0.33, 24.06]) 
increased the odds of low social support compared to married participants.   
 





OR 95% CI Wald df p-value 
Age  0.97 0.94-1.00 4.78 1 *0.03 
Gender       
   Male** 46(65.7) 1  5.15 1 *0.02 
   Female 120(80.0) 2.09 1.11-3.94    
Marital Status       
   Married** 96(68.1) 1  10.30 4 *0.04 
   Single  14(87.5) 3.28 0.72-15.05   0.13 
   Divorced 37(92.5) 5.78 1.69-19.75   *0.01 
   Widowed 6(85.7) 2.81 0.33-24.06   0.35 
     Partnered 9 (69.2%) 1.06 0.31-3.61   0.93 
Living situation       
   Not alone** 133(71.5) 1  5.84 1 *0.02 
   Alone 34(91.9) 4.51 1.33-15.34    
Annual household income 
(per year) 
      
   <$10,000** 10(83.3) 1  10.45 4 *0.03 
   $10,000-$24,999 28(90.3) 1.87 0.27-12.85   0.53 
   $25,000-$49,999 46(85.2) 1.15 0.21-6.23   0.87 
   $50,000-$99,999 49(66.2) 0.39 0.08-1.93   0.25 
   $100,000+ 22(68.8) 0.44 0.08-2.39   0.34 
Ethnicity       
    Hispanic, Latino/a or 
Spanish origin** 
7(63.6) 1  0.73 1 0.39 
    Not of Hispanic, Latino/a 
or Spanish origin 
158(75.2) 1.74 0.49-6.17    
Race       
   White** 155(74.9) 1  0.02 1 0.89 
   Non-white 11(73.3) 1.12 0.33-3.55    











As illustrated in Table 7, an MRC Dyspnea score of ≥3 or 4  was associated with 
lower social support (OR=3.97; p=0.12, 95%CI [0.69, 22.82]).  Those individuals who 
reported difficulty concentrating (OR=2.75; p =0.01, 95% CI [1.26, 6.02]), any pain 
within the prior 30 days (OR=1.04; p =0.01, 95% CI [1.07, 10.7]) or fatigue within the 










OR 95% CI Wald df p-value 
Condition       
   Alpha-1** 116(72.0) 1  2.44 1 0.12 
   Sarcoidosis 51(82.3) 1.80 0.86-3.76    
Genotype       
   ZZ** 65(74.7) 1  2.51 3 0.47 
   SZ 12(80.0) 1.35 0.35-5.25   0.66 
   MZ 19(61.3) 0.54 0.23-1.28   0.16 
   MS/SS/Other 10(71.4) 0.85 0.24-2.97   0.79 
Severity       
   Stage 1 or 2** 5(71.4) 1  0.35 1 0.55 
   Stage 3 or 4 14(82.4) 1.87 0.24-1465    
MRC Dyspnea Score       
   0** 17(77.3) 1  5.35 3 0.15 
   1 53(69.7) 0.678 0.22-2.06   0.49 
   2 68(73.9) 0.833 0.28-2.50   0.75 
   3 or 4 27(93.1) 3.97 0.69-22.82   0.12 
Family history of condition       
   No** 63(76.8) 1  1.24 1 0.27 
   Yes 68(69.4) 0.68 0.35-1.34    
Deaf or serious hearing difficulty       
   No** 154(74.8) 1  0.33 1 0.56 
   Yes 13(81.3) 1.46 0.40-5.34    
Blind or serious difficulty seeing       
   No** 150(73.9) 1  1.84 1 0.18 
   Yes 16(88.9) 2.28 0.63-12.71    
Difficulty concentrating, remembering or 
making decisions 
      
   No** 106(69.7) 1  6.40 1 *0.01 
   Yes 57(86.4) 2.75 1.26-6.02    
Difficulty walking or climbing stairs       
   No** 60(70.6) 1  1.58 1 0.21 
   Yes 107(78.1) 1.49 0.80-2.76    
Difficulty dressing or bathing       
   No** 112(72.7) 1  2.19 1 0.14 
   Yes 55(82.1) 1.72 0.84-3.53    
Difficulty doing errands alone       
   No** 101(70.6) 1  4.44 1 *0.04 
   Yes 66(83.5) 2.11 1.05-4.23    
Number days (in past 30) pain made usual 
activities hard 
 1.04 1.01-1.07 6.02 1 *0.01 
Number days (in past 30) fatigue made usual 
activities hard 
 1.06 1.03-1.09 13.84 1 *<0.001 
Number days (in past 7) left house or 
apartment  
 0.96 0.91-1.01 2.10 1 0.15 
Participates in online support groups       
   No** 85(70.2) 1  3.20 1 0.07 
   Yes 80(80.8) 1.78 0.95-3.36    
Participates in face to face support groups       
   No** 128(76.2) 1  0.54 1 0.46 
   Yes 37(71.2) 0.77 0.38-1.55    
Participates in advocacy groups       
   No** 126(74.6) 1  0.08 1 0.78 
   Yes 39(76.5) 1.11 0.53-2.31    
Participates in Groups/activities participated 
in outside the home 
      
   No** 60(88.2) 1  8.57 1 *0.003 
   Yes 107(69.0) 0.297 0.13-0.67    





As illustrated in Table 8, and in general, sarcoidosis patients perceived lower 
social support, although this group tended to report participating in online communities.  
Few of the sarcoidosis subjects interviewed spoke of participating in live support groups, 
and for those that did, the groups were small and sparsely attended.  Both groups utilized 
Facebook groups, although the usefulness of these groups appeared to be in question.  
The AATD participants spoke more often of family support, while the sarcoidosis 
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Overview of Manuscripts’ Contribution to the Question of Perceived Social 
Isolation and Social Support in Individuals with Alpha-1 Antitrypsin Deficiency or 
Sarcoidosis 
Results of a dimensional concept analysis of social isolation served as a 
springboard for the work leading to the dissertation study.  Findings from this analysis 
revealed that the central theme of having limited or low engagement in social networks is 
the defining characteristic of individuals experiencing perceived social isolation.  Often, 
this phenomenon occurs over time in individuals who live with a chronic illness.  
Individuals who exist in a stigmatized environment – perceived or actual – are at risk for 
social isolation (Chambers et al., 2015; Warren, 1993).  These individuals may benefit 
from such interventions as peer-based counseling, live support groups or internet-based 
support, and further study of these strategies is warranted.  A salient finding from the 
concept analysis was that social isolation remains widely defined, and a consensus 
definition has not yet been reached.  In the rare disease community, having cogent 
definitions of the various components of social isolation is critical in order to explore the 
phenomena, as having a rare disease can be an isolating experience (Patsos, 2001). Of the 
published studies reviewed to support the dimensional analysis, no studies were 
conducted in rare disease groups.  Following that concept analysis, an integrative review 
of existing instruments designed to measure perceived social isolation was conducted, 
using concepts aligned with the aspects of social isolation identified in the dimensional 





were identified as suitable candidates to be used in pilot study in rare disease patients.  
Ultimately, the six-item Friendship Scale was chosen as the instrument for the 
dissertation study.   
Since no published studies were identified that explored either perceived social 
isolation or social support in AATD or sarcoidosis patients, a convergent parallel mixed 
methods design was chosen to address this gap.  This approach facilitated quantitative 
measurement of the concepts, and also applied a patient-centric approach, whereby the 
narratives from qualitative interviews, conducted in a random subset of subjects, were 
compared with the perceived social isolation scores and social support scores on the 
instruments. 
The product of the dissertation was a robust overview and profile of patient 
perceptions of social isolation and social support that incorporates both quantitative 
scores as well as qualitative perspectives.  One finding of note was that despite the 
frequent use of the Internet and associated chat rooms, Facebook groups and other social 
media, many individuals were dissatisfied with the tone of these groups, and so sought to 
remove themselves from larger groups.  Occasionally, this was done in numbers, such 
that a breakaway subgroup of special interest patients was then formed, often as a private 
group.  This finding of the use of the Internet for support is supported by the literature 
(Patsos, 2001; Schumacher et al., 2014), but the concerns over the negative tones 
contributes to the existing knowledge.   
Subtle differences between the two populations became apparent during the data 
analyses.  In this study population, many of the AATD participants knew their genotype, 





In future studies, it may be prudent to determine the type of caregiver(s) that manage 
these patients, and the length of time that participants have been under  the current 
provider’s  care.  This could shed some light on the patient-clinician relationship, the 
ability of individuals to access specialist clinicians, as well as to the level of knowledge 
that the participant possesses.  This information would be helpful in order to inform 
future interventions.  There were more AATD participants who reported being active in 
face-to-face support groups than sarcoidosis participants, and conversely, a larger 
proportion of sarcoidosis participants who reported activity in online support groups than 
AATD individuals.  This may be driven in part by the paucity of live support groups 
available to sarcoidosis patients, and also due to the influence and reach of the groups 
sponsored by the Alpha-1 Foundation.    
The AATD population in this study scored higher on both instruments, indicating 
more perceived social support and less isolation than the sarcoidosis participants, 
although the AATD population still scored “somewhat isolated”.   Both groups scored as 
perceiving low to normal social support, with the sarcoidosis participants reporting lower 
social support than their AATD counterparts.  The AATD group frequently mentioned 
the presence and impact of the Alpha-1 Foundation and its organized communities, and in 
fact, this group as a whole reported more frequent participation in face to face support 
groups than the sarcoidosis participants.  Of note is the fact that by nature, social isolation 
is likely to be difficult to alleviate in traditional one-on-one interventions, as this 
phenomenon may be more embedded in varying levels of interpersonal interaction than 
other social phenomena or social challenges (Cruwys et al., 2014). For example, although 





interventions as well as group settings.  One working hypothesis is that due to the 
“forced” social interaction afforded by these live groups, individuals obtained more 
benefit than those who engaged (usually alone) via their computer, but this study was not 
designed to test this hypothesis.  Future studies could be designed to assess the magnitude 
of involvement with a participant’s respective support group or system, in order to tease 
out further insights.   
Various predictors of perceived social isolation and social support were identified 
in the study. Single and divorced persons and those that lived alone had higher odds of 
reporting social isolation, as did females.  Those with impaired functional capacity, as 
measured by perceived breathlessness, or more severe sarcoidosis (as measured by 
staging), were more likely to report feeling isolated.  Individuals who reported challenges 
with certain activities of daily living such as concentrating, walking up stairs , 
dressing/bathing, doing errands or who reported pain, fatigue or visual impairments also 
had higher odds of reporting significant isolation compared to their counterparts reporting 
less impairment.   
Similar results were noted when exploring predictors of low social support.  
Females were twice as likely as their male counterparts to report feelings of low social 
support. Individuals who were single, divorced or widowed or lived alone also had higher 
odds of reporting low social support than those who were married or lived with someone.  
Individuals who experienced high levels of dyspnea had more than twice the odds of 
reporting low social support.  Individuals who reported difficulty concentrating, pain, or 






Limitations of Dissertation Research  
 Limitations of the research are provided within each manuscript.  For the concept 
analysis of social isolation, there was little published literature identified regarding the 
phenomenon in individuals with chronic lung disease.  There were also challenges with 
searching for literature on the phenomenon:  since the concept remains somewhat open to 
interpretation, the term “loneliness” is often used interchangeably with “social isolation”.  
The same limitation was found when searching the literature for the integrative review of 
instruments.  In addition, the psychometrics of the instruments were reported 
inconsistently, and this proved to make for a challenge in ensuring equitable 
comparisons.  In terms of the dissertation study, the populations of interest were accessed 
in two different ways.  The alpha-1 participants were already part of an existing registry, 
and so there may have been some bias in terms of their willingness to participate in this 
study.  The sarcoidosis participants were generally contacted via convenience or snowball 
sampling, and were typically not part of an established unit, such as the MUSC Alpha-1 
Registry.   Limitations related to lack of computer access cannot be dismissed, and have 
been noted in other studies of sarcoidosis patients.  In the U.S., sarcoidosis 
disproportionately affects African-Americans(Rybicki, Major, Popovich, Maliarik, & 
Iannuzzi, 1997), who often face other economic challenges.  Specific challenges relating 
to the recruiting of these  individuals were underscored by Dr. Alicia Gerke in regard to 
her survey of sarcoidosis patients (Crouser & Judson, 2015).  Limited access to the 
internet, failure to complete the surveys, disengagement from healthcare providers and a 
related lack of trust, such as concerns about protection of their personal information, were 





in the U.S., and per the study protocol, were required to have computer access in order to 
complete the survey; this may limit the generalizability of the findings.   
Lessons Learned 
 The relative ease of recruiting the proposed sample – both in terms of recruitment 
time and numbers –was not anticipated.  The role of the existing MUSC Alpha-1 registry 
coordinator, who had already established a relationship with the Alpha-1 population, 
even if only via email, cannot be understated.  This registry coordinator was invaluable in 
the initial engagement of the potential study participants from this population.  The 
investigator had an established relationship with a number of active sarcoidosis patients 
who reached out to their  own networks, and this snowball sampling approach also 
benefitted the study enrollment.   The investigator was transparent in disclosing that she 
was not diagnosed with either condition, and that this work was to support a doctoral 
study and pursuit of an academic credential.  This transparency seemed to facilitate open 
dialogue between subject and investigator.   
 Further characterization of the population in terms of functional capacity would 
have been helpful in order to consider physical limitations that could affect individuals’ 
mobility and ability to move about within their communities.  The investigator collected 
information about genotype (in the case of the Alpha-1 population) or staging (in the case 
of the sarcoidosis population), as well as breathlessness via subject self-report on a 
dyspnea scale.  Future studies would be well-served to collect additional information 







Importance of theory, model or framework to guide overall findings 
 Social network theory suggests that there is a positive effect of social networks 
and social support on an individual’s coping resources, as well as the community 
resources that they are able to access(Heaney & Israel, 2008).  Heaney suggested that 
social networks and social ties can enhance an individual’s overall health status, facilitate 
the gathering of information, and ultimately, contribute to an individual’s ability to 
problem-solve (Heaney and Israel, 2008).  This illustration of the relationship between 
social networks and social support, and an individual’s overall health status was the 
overarching hypothesis referenced for the design of this study - individuals who accessed 
support would be less likely to perceive isolation or low social support, irrespective of 
the type of support that they accessed.   An individual’s social network, consisting of 
both individual and community resources, was also hypothesized to be linked to the 
robustness of one’s connectedness and feelings of support.  Our findings are somewhat 
contradictory to the model, and suggest that for some individuals (such as the sarcoidosis 
population in our study), accessing support is not necessarily associated with less social 
isolation and higher social support scores.  These findings, however, should be 
interpreted with caution, as more information would be needed (such as comorbidities, 
concomitant medications, etc) in order to draw causal inferences. 
Research Trajectory 
Further research in this area is warranted. This dissertation was designed as an 
exploratory study and was conducted with a small sample that was limited to a population 
the investigator could access with relative ease.  Larger studies are needed that explore 





studies should also enroll participants from a variety of settings, including live or ground-
based clinics and/or support groups, in order to compare similarities and differences.  
Future studies should also include measures to further characterize the population, such 
as including oxygen and concomitant medication use.  An ideal approach would be to 
convene a group of stakeholders and harness the power of a community-based 
participatory research approach, in order to design studies that not only answer the 
research question(s) of interest to the investigator, but also to explore issues that are 
important to patients.  Findings from such studies could then be used to design 
interventional studies of various modalities to lessen the perceptions of social isolation or 
increase social support.  Future research might also include studies to compare the effects 
of face to face groups with virtual groups on perceptions of social isolation and social 
support, and/or peer-led groups compared to groups led by a trained facilitator on those 
same perceptions.   
 Contribution of Research to Science and Nursing  
  Nursing research is sparse on the experience of living with a rare disease 
(Wagner, Christensen, & Coleman, 2015), and is even more lacking on the concept of 
social isolation in the rare disease population, although recent studies are beginning to 
address this gap (Garrino et al., 2015; Hoth et al., 2014; Wienke et al., 2014).  This 
dissertation contributes to the science of nursing by calling attention to this need, and by 
highlighting some of the gaps in the published literature on social isolation and social 
support in two rare lung diseases. The findings from this study contribute to current 
knowledge by identifying similarities and differences that exist between two similar, yet 





the different ways in which individuals seek support.  Findings further suggest that there 
is a need to explore the framework from which that support stems, whether via 
established organizations such as the Alpha-1 Foundation, or more peer-based support 
groups, such as Facebook chat rooms and the like.  Finally, this study addressed the 
alpha-1 and sarcoidosis populations, isolating issues in these populations. 
Although the generalizability of the findings from this exploratory study is 
limited, the study design and results are valuable. Depending upon the condition, a rare 
disease population can be geographically dispersed.  In the case of the ultra-rare diseases, 
there may be only a few documented cases.  By utilizing the power of the internet, 
combined with existing resources such as the MUSC registry coordinator, this study’s 
investigators were able to enroll a sample of subjects from across the United States, with 
diverse demographics.  Although this is a limitation as mentioned previously, this also 
provides evidence to support the utility of this approach.  No longer are researchers 
confined by brick and mortar walls.  Indeed, some of the ultra-rare conditions are 
utilizing a virtual approach to collect data.  Marshall-Smith Syndrome is a condition that 
is known to affect approximately fifty people worldwide.  A global collaboration using an 
online wiki to facilitate data collection and sharing has brought together clinicians and 
scientists to harness the power of the group(Shaw et al., 2010).  This dissertation study 
and other studies, similar to the Shaw study, provide compelling evidence to support such 
non-traditional approaches.  Establishment of such registries is not new to the alpha-1 
community.  By 2005, following the recommendation of the World Health Organization, 
the Alpha One International Registry included 21 countries on four continents, and is 





(Gupta, Bayoumi, & Faughnan, 2011). The registry has facilitated epidemiologic as well 
as interventional studies, and is similar to the MUSC Alpha-1 Registry from which 
subjects for this study were recruited.  In the future, scientists and other clinicians may 
find the virtual approach used by this dissertation study to be useful when considering 
how best to collect information from their own populations of interest.   
The results of this study may be of particular interest to organizations representing 
rare disease groups, especially the results which suggest that an organized framework and 
some measure of shepherding by peers or other navigators could prove beneficial to 
patients, especially at the initial diagnosis.  The use of peer-navigators has been explored 
in a variety of conditions, including chronic obstructive pulmonary disease (COPD), 
spinal cord injury, and breast cancer (Mollica, Nemeth, Newman, Mueller, & Sterba, 
2014; Newman et al., 2014; Thomashow et al.).  Registries that maintain large numbers 
of patients with a given condition have also shown to be useful in contributing to current 
and future studies(Strange et al., 2015).  By encouraging the nurse scientists of today to 
think “out of the box” in anticipation of tomorrow, future work can truly build on the 
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ADDITIONAL TABLES OF INTEREST TO SUPPORT DISSERTATION STUDY 
 
Table 1 Demographic Characteristics of Pooled Study Population and By Condition 






Age, mean (sd) 56.6 (11.4) 59.4 (11.4) 50.1 (8.3) <0.001 
Gender, n (%)     
     Male 76(31.5) 65(37.4) 11(16.4) 0.002 
     Female 165(68.5) 109(62.6) 56(83.6)  
Marital status, n (%)     
     Married 154(64.7) 113(65.7) 41(62.1) 0.317 
     Single 17(7.1) 12(7.0) 5(7.6)  
     Divorced 43(18.1) 27(15.7) 16(24.2)  
     Widowed 7(2.9) 7(4.1) 0  
     Partnered 17(7.1) 13(7.6) 4(6.1)  
Living situation, n (%)     
     Alone 39(16.2) 32(18.4) 7(10.4) 0.003 
     With spouse/life partner 117(48.5) 93(53.4) 24(35.8)  
     With children 16(6.6) 7(4.0) 9(13.4)  
     With spouse/life partner & children 54(22.4) 33(19.0) 21(31.3)  
     With a friend 5(2.1) 2(1.1) 3(4.5)  
     Other  10(4.1) 7(4.0) 3(4.5)  
Annual household income (per year)     
   <$10,000 15(6.8) 10(6.1) 5(8.6) 0.829 
   $10,000-$24,999 34(15.4) 24(14.7) 10(17.2)  
   $25,000-$49,999 58(26.2) 42(25.8) 16(27.6)  
   $50,000-$99,999 81(36.7) 63(38.7) 18(31.0)  
   $100,000+ 33(14.9) 24(14.7) 9(15.5)  
Ethnicity     
    Hispanic, Latino/a or Spanish origin 14(5.8) 8(4.5) 6(9.1) 0.216 
    Not of Hispanic, Latino/a or Spanish  
    origin 
228(94.2) 168(95.5) 60(89.6)  
Race     
   White 226(93.0) 173(98.3) 53(79.1) <0.001 
   Black or African American  11(4.5) 1(0.6) 10(14.9)  
   American Indian or Alaska Native 1(0.4) 0 1(1.5)  
   Asian Indian 1(0.4) 0 1(1.5)  
   Other 4(1.6) 1(0.6) 3(4.5)  





Table 2 Clinical Characteristics: Pooled Study Population and By Condition 






Genotype (alpha-1), n(%)     
   ZZ  97(55.7)   
   SZ  18(10.3)   
   SS  5(2.9)   
   MZ  32(18.4)   
   MS  1(0.6)   
   Other  11(6.3)   
   I don’t know  10(5.7)   
Severity (sarcoidosis), n(%)     
   Stage 1   3(4.6)  
   Stage 2   5(7.7)  
   Stage 3   9(13.8)  
   Stage 4   9(13.8)  
   I don’t know   39(60.0)  
MRC Dyspnea Score, n(%)     
   0 27(11.3) 19(10.9) 8(12.3) 0.634 
   1 82(34.2) 64(36.6) 18(27.7)  
   2 97(40.4) 66(37.7) 31(47.7)  
   3 26(10.8) 20(11.4) 6(9.2)  
   4 8(3.3) 6(3.4) 2(3.1)  
MRC Dyspnea Score, median(IQR) 2(1-2) 2(1-2) 2(1-2) 0.657 
MRC Dyspnea Score, mean (sd) 1.6(0.9) 1.6(0.9) 1.6(0.9)  
Number of years with condition, 
median(IQR) 
7(3-13) 7(3-14) 6(3-12) 0.347 
Number of years with condition, mean (sd) 10.0(10.7) 10.4(11.4) 8.8(8.7)  
Family history of condition, n(%) 105(53.8) 98(70.0) 7(12.7) <0.001 
Deaf or serious hearing difficulty, n(%) 18(7.4) 12(6.8) 6(9.0) 0.588 
Blind or serious difficulty seeing, n(%) 23(9.5) 11(6.3) 12(17.9) 0.006 
Difficulty concentrating, remembering or 
making decisions, n(%) 
71(29.7) 37(21.5) 34(50.7) <0.001 
Difficulty walking or climbing stairs, n(%) 149(61.3) 110(62.5) 39(58.2) 0.539 
Difficulty dressing or bathing, n(%) 71(29.3) 55(31.3) 16(24.2) 0.286 
Difficulty doing errands alone, n(%) 88(36.2) 57(32.4) 31(46.3) 0.044 
Number days (in past 30) pain made usual 
activities hard, median (IQR) 
2(0-20) 0(0-10) 18(2-30) <0.001 
Number days (in past 30) pain made usual 
activities hard, mean (sd) 
9.4(11.9) 6.6(10.4) 16.7(12.8)  
Number days (in past 30) fatigue made 
usual activities hard, median (IQR) 
15(3-30) 10(2-30) 20(10-30) 0.005 
Number days (in past 30) fatigue made 
usual activities hard, mean (sd) 
15.8(13.9) 14.6(14.7) 18.7(11.2)  
Number times (in past 7days) left house or 
apartment median (IQR) 
5(3-7) 5(3-9) 4(2-7) 0.012 
Number times (in past 7days) left house or 
apartment, mean (sd) 
6.6(5.8) 7.1(6.2) 5.0(4.4)  
Participates in face to face support groups, 
n(%) 
55(22.8) 46(26.3) 9(13.6) 0.037 
Number participated in in past year, 
median(IQR) 
4(2.8-6.0) 4(3-5) 6(1-12) 0.578 
Number participated in in past year, mean 
(sd) 
4.8(3.7) 4.5(3.3) 6.3(5.2)  
Participates in online support groups, n(%) 107(44.4) 49(28.0) 58(87.9) <0.001 
Participates in advocacy groups 56(23.2) 41(23.3) 15(23.1) 0.972 
Groups/activities participated in outside the 
home 
    
   Church 73(29.9) 50(28.2) 23(34.3) 0.356 
   School/school groups 23(9.4) 14(7.9) 9(13.4) 0.188 
   Sport 51(20.9) 45(25.4) 6(9.0) 0.005 
   Book clubs 11(4.5) 9(5.1) 2(3.0) 0.732 
   Social clubs 38(17.5) 31(17.5) 7(10.4) 0.175 
   Other 89(36.5) 70(39.5) 19(28.4) 0.106 













Friendship Scale*     
   Very easy to complete 130(53.9) 97(55.4) 33(50.0) 0.091 
   Easy to complete 86(35.7) 65(37.1) 21(31.8)  
   Hard to complete 23(9.5) 12(6.9) 11(16.7)  
   Very hard to complete 2(0.8) 1(0.6) 1(1.5)  
MOS-SSS**     
   Very easy to complete 129(54.0) 98(56.3) 31(47.7) 0.009 
   Easy to complete 84(35.1) 64(36.8) 20(30.8)  
   Hard to complete 25(10.5) 12(6.9) 13(20.0)  






Table 4 Average Friendship Scale and Medical Outcomes Scale – Social Support Survey (MOS-
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Table 5 Friendship Scale and Medical Outcomes Scale – Social Support Survey (MOS-SSS) by 
Study Population and Condition by Access to Support 









   
All respondents        
Total, N 134  108     








15256.5 -1.211 0.226 










15087.0 -0.958 0.338 










15589.5 -0.354 0.723 










14922.5 -0.933 0.351 










15080.5 -0.157 0.875 










13930.5 -0.635 0.526 
Alpha-1        
Total, N 75  100     








8153.5 -0.734 0.463 
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8198.0 -0.877 0.380 










7963.0 -1.104 0.270 










8004.5 -0.505 0.614 










7319.0 -0.754 0.451 
Sarcoidosis        
Total, N 59  8     








1836.5 -2.096 0.036 










1888.5 -1.072 0.284 










1893.0 0.988 0.323 










1759.0 -1.275 0.202 










1845.5 -1.476 0.140 

















Table 6 Logistic Regression Analyses:  Association between Demographic Characteristics 
and Perceived Social Isolation 
 Isolated, 
n(%) 
OR 95% CI Wald df p-value 
Age  0.96 0.94-0.99 8.37 1 0.004 
Gender       
   Male 33(43.4) 1  6.92 1 0.009 
   Female 100(61.7) 2.10 1.21-3.66    
Marital Status       
   Married 71(47.0) 1  14.66 4 0.005 
   Single  13(76.5) 3.66 1.14-11.74    
   Divorced 33(76.7) 3.72 1.71-8.08    
   Widowed 3(42.9) 0.85 0.18-3.91    
   Partnered 9(52.9) 1.27 0.46-3.46    
Living situation       
   Not alone 105(52.5) 1  4.75 1 0.029 
   Alone 28(71.8) 2.30 1.09-4.88    
Annual household income 
(per year) 
      
   <$10,000 11(78.6) 1  19.25 4 0.001 
   $10,000-$24,999 27(79.4) 1.05 0.23-4.83    
   $25,000-$49,999 38(65.5) 0.52 0.13-2.07    
   $50,000-$99,999 34(42.5) 0.20 0.05-0.78    
   $100,000+ 14(43.8) 0.21 0.05-0.91    
Ethnicity       
    Hispanic, Latino/a or 
Spanish origin 
7(53.8) 1  0.01 1 0.715 
    Not of Hispanic, Latino/a 
or Spanish origin 
124(55.4) 1.06 0.35-3.26    
Race       
   White 123(55.2) 1     






Table 7 Logistic Regression Analyses:  Associations between Clinical Characteristics and 
Perceived Social Isolation 
 Isolated, 
n(%) 
OR 95% CI Wald df p-value 
Condition       
   Alpha-1 90(52.0) 1  3.30 1 0.069 
   Sarcoidosis 43(65.2) 1.72 0.96-3.10    
Genotype       
   ZZ 49(51.6) 1  2.03 3 0.567 
   SZ 9(50.0) 0.94 0.34-2.57    
   MZ 19(59.4) 1.37 0.61-3.09    
   MS/SS/Other 6(37.5) 0.56 0.19-1.67    
Severity       
   Stage 1 or 2 3(37.5) 1  4.49 1 0.034 
   Stage 3 or 4 14(82.4) 7.78 1.17-51.92    
MRC Dyspnea Score       
   0 14(51.9) 1  11.16 3 0.010 
   1 34(44.4) 0.74 0.31-1.78    
   2 54(57.4) 1.25 0.53-2.96    
   3 or 4 27(79.4) 3.58 1.17-11.01    
Blind or serious difficulty 
seeing 
      
   No 115(53.2) 1  4.31 1 0.038 
   Yes 17(77.3) 2.99 1.06-8.38    
Difficulty concentrating, 
remembering or making 
decisions, 
      
   No 70(42.4) 1  29.7 1 <0.001 
   Yes 59(84.3) 7.28 3.57-14.86    
Difficulty walking or 
climbing stairs 
      
   No 35(37.6) 1  19.33 1 <0.001 
   Yes 98(67.1) 3.38 1.97-5.83    
Difficulty dressing or bathing       
   No 83(49.1) 1  10.45 1 0.001 
   Yes 50(72.5) 2.73 1.48-5.01    
Difficulty doing errands alone       
   No 68(44.7) 1  19.17 1 <0.001 
   Yes 65(75.7) 3.65 2.04-6.52    
Number days (in past 30) pain 
made usual activities hard 
 1.07 1.04-1.10 23.6 1 <0.001 
Number days (in past 30) 
fatigue made usual activities 
hard 
 1.06 1.04-1.09 27.12 1 <0.001 
Number days (in past 7) left 
house or apartment  
 0.92 0.87-0.96 12.03 1 0.001 
Participates in online support 
groups 
      
   No 71(54.2) 1  0.27 1 0.606 
   Yes 61(57.5) 1.15 0.68-1.92    
Participates in face to face 
support groups 
      
   No 107(58.8) 1  3.01 1 0.083 
   Yes 25(45.5) 0.58 0.32-1.07    
Participates in advocacy 
groups 
      
   No 103(56.9) 1  0.823 1 0.364 
   Yes 28(50.0) 0.757 0.42-1.38    
Participates in 
Groups/activities participated 
in outside the home 
      
   No 55(76.4) 1  16.88 1 <0.001 





Table 8 Logistic Regression Analyses:  Associations between Demographic Characteristics 





OR 95% CI Wald df p-value 
Age  0.97 0.94-1.00 4.78 1 0.029 
Gender       
   Male 46(65.7) 1  5.15 1 0.023 
   Female 120(80.0) 2.09 1.11-3.94    
Marital Status       
   Married 96(68.1) 1  10.30 4 0.036 
   Single  14(87.5) 3.28 0.72-15.05    
   Divorced 37(92.5) 5.78 1.69-19.75    
   Widowed 6(85.7) 2.81 0.33-24.06    
     Partnered 9 (69.2%) 1.06 0.31-3.61    
Living situation       
   Not alone 133(71.5) 1  5.84 1 0.016 
   Alone 34(91.9) 4.51 1.33-15.34    
Annual household income 
(per year) 
      
   <$10,000 10(83.3) 1  10.45 4 0.033 
   $10,000-$24,999 28(90.3) 1.87 0.27-12.85    
   $25,000-$49,999 46(85.2) 1.15 0.21-6.23    
   $50,000-$99,999 49(66.2) 0.39 0.08-1.93    
   $100,000+ 22(68.8) 0.44 0.08-2.39    
Ethnicity       
    Hispanic, Latino/a or 
Spanish origin 
7(63.6) 1  0.73 1 0.394 
    Not of Hispanic, Latino/a 
or Spanish origin 
158(75.2) 1.74 0.49-6.17    
Race       
   White 155(74.9) 1  0.018 1 0.894 











OR 95% CI Wald df p-value 
Condition       
   Alpha-1 116(72.0) 1  2.44 1 0.118 
   Sarcoidosis 51(82.3) 1.80 0.86-3.76    
Genotype       
   ZZ 65(74.7) 1  2.51 3 0.473 
   SZ 12(80.0) 1.35 0.35-5.25    
   MZ 19(61.3) 0.54 0.23-1.28    
   MS/SS/Other 10(71.4) 0.85 0.24-2.97    
Severity       
   Stage 1 or 2 5(71.4) 1  0.353 1 0.553 
   Stage 3 or 4 14(82.4) 1.87 0.24-1465    
MRC Dyspnea Score       
   0 17(77.3) 1  5.35 3 0.148 
   1 53(69.7) 0.678 0.22-2.06    
   2 68(73.9) 0.833 0.28-2.50    
   3 or 4 27(93.1) 3.97 0.69-22.82    
Family history of condition       
   No 63(76.8) 1  1.24 1 0.265 
   Yes 68(69.4) 0.68 0.35-1.34    
Deaf or serious hearing difficulty       
   No 154(74.8) 1  0.33 1 0.564 
   Yes 13(81.3) 1.46 0.40-5.34    
Blind or serious difficulty seeing       
   No 150(73.9) 1  1.84 1 0.175 
   Yes 16(88.9) 2.28 0.63-12.71    
Difficulty concentrating, 
remembering or making decisions 
      
   No 106(69.7) 1  6.40 1 0.011 
   Yes 57(86.4) 2.75 1.26-6.02    
Difficulty walking or climbing stairs       
   No 60(70.6) 1  1.58 1 0.209 
   Yes 107(78.1) 1.49 0.80-2.76    
Difficulty dressing or bathing       
   No 112(72.7) 1  2.19 1 0.139 
   Yes 55(82.1) 1.72 0.84-3.53    
Difficulty doing errands alone       
   No 101(70.6) 1  4.44 1 0.035 
   Yes 66(83.5) 2.11 1.05-4.23    
Number days (in past 30) pain made 
usual activities hard 
 1.04 1.01-1.07 6.02 1 0.014 
Number days (in past 30) fatigue 
made usual activities hard 
 1.06 1.03-1.09 13.84 1 <0.001 
Number days (in past 7) left house or 
apartment  
 0.96 0.91-1.01 2.10 1 0.148 
Participates in online support groups       
   No 85(70.2) 1  3.20 1 0.074 
   Yes 80(80.8) 1.78 0.95-3.36    
Participates in face to face support 
groups 
      
   No 128(76.2) 1  0.54 1 0.464 
   Yes 37(71.2) 0.77 0.38-1.55    
Participates in advocacy groups       
   No 126(74.6) 1  0.08 1 0.782 
   Yes 39(76.5) 1.11 0.53-2.31    
Participates in Groups/activities 
participated in outside the home 
      
   No 60(88.2) 1  8.57 1 0.003 






Table 10 Reliability of Friendship Scale and MOS-SSS:  By Study Population and Disease 
Condition 
 All 





Friendship scale 0.915 0.912 0.920 
MOS-SSS emotional/ informational support 0.961 0.962 0.953 
MOS-SSS tangible support 0.960 0.959 0.961 
MOS-SSS positive social interaction 0.961 0.964 0.959 
MOS-SSS affectionate support 0.964 0.960 0.971 






Table 11 Convergent Validity 
 Correlation with Friendship 
Scale, r 
p-value 
MOS-SSS emotional/ informational support 0.737 <0.001 
MOS-SSS tangible support 0.598 <0.001 
MOS-SSS positive social interaction 0.611 <0.001 
MOS-SSS affectionate support 0.713 <0.001 
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Appendix F Demography Instrument (created by PI and refined by Dissertation Committee) 
 
Demographic / Clinical Questionnaire 
Age [Text Box]:    Please enter your actual age (in years)_____ 
  
Ethnicity* Are you Hispanic, Latino/a, or Spanish origin 
(one or more categories may be selected) 
 !   No, not of Hispanic, Latino/a, or Spanish 
origin 
 !   Yes, Mexican, Mexican American, Chicano/a 
 !   Yes, Puerto Rican 
 !   Yes, Cuban 
  
Race* What is your race? 
 !   White 
 !   Black or African American 
 !   American Indian or Alaska Native 
 !   Asian Indian 
 !   Chinese 
 !   Filipino 
 !   Japanese 
 !   Korean 
 !   Vietnamese 
 !   Other Asian 
 !   Native Hawaiian 
 !   Guamanian or Chamorro 
 !   Samoan 
 !   Other Pacific Islander 
 !   Other 
  
Disability status*  
During the past 30 days, for 
about how many days did 
pain make it hard for you to 
do your usual activities, 
such as self-care, work, or 
recreation? [TEXT BOX] 
___ days 
During the past 30 days, for 
about how many days did 
fatigue or being extremely 
tired make it hard for you to 
do your usual activities, 







Age [Text Box]:    Please enter your actual age (in years)_____ 
recreation? [TEXT BOX] 
Are you deaf or have 
serious difficulty hearing? 
!Yes 
 !  No 
Are you blind or do you 
have serious difficulty 
seeing, even when wearing 
glasses? 
!Yes 
 !  No 
Because of a physical, 
mental or emotional 
condition, do you have 
serious difficulty 
concentrating, 
remembering, or making 
decisions? 
!Yes 
 !  No 
Do you have serious 
difficulty walking or 
climbing stairs? 
!Yes 
 !  No 
Do you have difficulty 
dressing or bathing? 
!Yes 
 !  No 
Because of a physical, 
mental, or emotional 
condition, do you have 
difficulty doing errands 
alone such as visiting a 
doctor’s office or 
shopping?  
!Yes 
How many times have you 
left your house/apartment 
in the past week? 
<Free text entry> 
 !  No 
  
Gender !   Male 
 !   Female 
  
Marital Status !   Married 
 !   Single 





Age [Text Box]:    Please enter your actual age (in years)_____ 
 !   Widowed 
 !   Partnered (in a committed relationship) 
  
Living Situation !   I live alone 
 !   I live with a spouse / life partner 
 !   I live with my child/children 
 !   I live with spouse / life partner & 
child/children 
 !   I live with a friend 
 !   Other 
  
Annual income in the home !  < $10,000/year 
 !   $10,000 - $24,999/year 
 !   $25,000 – $49,999/year 
 !   $50,000 – $99,999/year 
 !  ≥ $100,000/year 
  
Number of years since 
diagnosis 
 Enter actual number of years.  If less than 1 
year, enter “0”:  ____ 
  
Condition !   Alpha-1 
 !   Sarcoidosis 
  
Genotype (if alpha-1) !   ZZ 
 !   SZ 
 !   SS 
 !   MZ 
 !   MS 
 !   Do not know 
  
Disease severity (if 
sarcoidosis) !  Stage 1 
 !  Stage 2 
 !  Stage 3 
 !  Stage 4 
 !   Do not know 
  
Is another family member 
involved who has the 
disease 





Age [Text Box]:    Please enter your actual age (in years)_____ 
 !  No 
Do you participate in online 
support groups? 
!  Yes 
 !  No 
Do you participate in face-
to-face support groups? 
!Yes 
 !  No 
If “yes”, how many face-to-
face support groups per 
year do you participate in? 
____ [free text box] 
Do you participate in any 
advocacy groups 
!Yes 
 !  No 
  
Do you participate in any 
activities/groups outside of 
the home?  (Check all that 
apply) !   Church 
 !   School / school groups 
 !   Sporting/physical activity 
 !   Book clubs 
 !   Social clubs 
 !   Other  
*Categories adopted from Office of Minority Health. Final data collection standards for race, 
ethnicity, 
primary language, sex, and disability status required by section 4302 of the Affordable Care Act. 
























Appendix I Medical Outcomes Survey – Social Support Scale (MOS-SSS) 
Running Head:  Social Isolation and Social Support in Alpha-1 and Sarcoidosis 
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Appendix K The modified Medical Research Council (mMRC) Dyspnea Score 
 
Level of Dyspnea Grade 
1.  I only get breathless with strenuous exercise. 0 
2.  I get short of breath when hurrying on level ground 
or walking up a slight hill. 
1 
3.  On level ground, I walk slower than people of the 
same age because of breathlessness, or I have to 
stop for breath when walking at my own pace on the 
level 
2 
4.  I stop for breath after walking about 100 yards or 
after a few minutes on level ground 
3 
5.  I am too breathless to leave the house or I am 
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A. SPECIFIC AIMS_____________________________________________________ 







The purpose of this parallel convergent mixed-methods study is to describe perceptions of the 
social impact of living with one of two rare diseases.  The study will be guided by an interpretative 
phenomenological approach, using semi-structured interviews and quantitative measurement of 
perceived social isolation as measured by the Friendship Scale and perceived availability of 
social support as measured by the Medical Outcomes .  Qualitative data will be obtained via 
interviews, transcribed, and analyzed via nVivo10.  Quantitative data will be obtained via 
participant completion of the Friendship Scale and the MOS-SSS, coded and uploaded into SPSS 
v22 for analysis. Findings will be linked by a study ID number for comparison.    
The rationale that underlies the proposed research is that prior to undertaking any large study to 
assess the presence and magnitude of perceived effect of living with a rare disease on social 
interactions, one must understand how it presents, what may ameliorate it, and what potential 
interventions might be useful.   
SPECIFIC AIMS 
Aim #1:  To explore perceptions of the social impact of living with rare disease by assessing 
perceptions of social isolation, social support, connectedness, social participation and 
relationships in adults with two rare lung diseases, AATD and sarcoidosis, in an academic center 
and/or via the Web using one-on-one interviews.   
Aim #2: To compare the Friendship Scale (Appendix 2) and the MOS-SSS (Appendix 3) in 
individuals who have ever accessed compared to never accessed a support group in Alpha-1 and 
Sarcoidosis. We will also evaluate these tools as measures of perceived social isolation and 
availability of social support, respectively.  
Aim #3: Triangulate the survey and interview results to identify areas for development of 
interventions and preferences to improve individuals’ preferred level of social interaction. 
Expected Results: The results will reveal some degree of social isolation in both groups, and the 
isolation may be directly correlated with involvement in support groups (participation in online or 
face-to-face groups = decreased perceived social isolation and perceptions of increased social 
support). 
Conclusion/Implications:  The findings of the study will provide preliminary information useful 
for refining hypotheses related to perceived social isolation and social support in rare disease 
patients and to inform future intervention development. 
 
 
B. BACKGROUND AND SIGNIFICANCE_________________________________ 
 
Many rare diseases are chronic, complex and associated with physical, intellectual or 
neurological disabilities (Anderson, Elliott, & Zurynski, 2013).  These conditions often accompany 
significant psychosocial and emotional impact for patients and families, compounded by a lack of 
support services.  Functional limitations and the lack of support services can lead to perceptions 
of social isolation.  Over the past three decades, social isolation as a variable has been shown to 
be predictive of mortality and morbidity in general population samples (House, 2001; House, 
Umberson, & Landis, 1988, Brummet, et al, 2001) and in studies of diseased populations, 
especially those suffering from cardiac disease (Berkman, 1995; Berkman & Syme, 1979 ).  
Insight into factors contributing to perceptions of social isolation can be useful in designing health 
promotion interventions (Berkman, 1995). Despite the number affected, rare disease patients 
often feel isolated and unable to get the information and support needed (Colledge & Solly, 
2012). Few published studies explore the psychosocial impact of living with a rare disease 
(Wienke et al., 2014; Acorn, Joachim, & Wachs, 2003; Henderson, Packman, & Packman, 2009; 
Stoller, Smith, Yang, & Spray, 1994).  No published studies on social isolation in rare diseases 
were identified, despite the fact that this phenomenon is repeatedly verbalized by individuals who 
suffer from both diseases (personal communications, M. Judson, 2012, W. Hunter, 2013) and the 
fact that individuals are encouraged to seek support (Lasker, Sogolow, & Sharim, 2005).  Indeed, 
the authors of a recent study of the association between the social environment and uncertainty 
among a sample of patients with alpha-1 antitrypsin deficiency (AATD)-associated COPD have 
called for more work evaluating the impact of social isolation and loneliness on individuals with 





and its presentation in these individuals remains unknown.  The risk of social isolation may be 
high for persons with rare diseases such as sarcoidosis and alpha-1 antitrypsin deficiency 
(AATD).   
The long-term goal of this study is to refine hypotheses related to the perceived effect of living 
with a rare disease on social interactions experienced by individuals with AATD and sarcoidosis 
and to inform future intervention development.  The overall objective of this study is to gain insight 
into perceptions of the social impact, particularly social isolation and social support, and its 
consequences as experienced by individuals with AATD and sarcoidosis.  The overarching 
question driving this proposal is:  To what extent do individuals with the rare lung diseases of 
AATD and sarcoidosis perceive the social impact and consequences of living with these diseases 
as documented via participant self-report and as measured by the Friendship Scale and the 
Medical Outcomes Study – Social Support Survey (MOS-SSS).  The rationale for this study is 
that results may yield information useful for refining hypotheses related to perceived social 
isolation and social support in rare diseases and to inform future intervention development. 
 
An estimated 10% of Americans live with a diagnosis of one of the 6,000 to 8,000 known rare 
diseases (Griggs et al., 2009).  The experience of living with a rare condition is complex and can 
significantly affect the individual’s quality of life (Cohen & Biesecker, 2010).  Many studies have 
adopted a population-based approach to rare diseases, but the patients’ viewpoint on having 
such a disorder has remained unattended (Huyard, 2009).  These patients can experience a 
myriad of psychosocial effects, including social stigma, lack of social support, and perceptions of 
social isolation.  In general, social isolation is gaining increased attention as an integral 
component of health (World Health Organization, 2002) and the link between social isolation and 
health is one focus of the National Research Council’s (National Research Council, 2001) interest 
in integrative health.  Social isolation as a variable repeatedly showed a predictive relationship to 
mortality and serious morbidity both in general population samples (House, 2001; House, 
Umberson, & Landis, 1988) and in studies of diseased populations, especially those suffering 
from cardiac disease (Berkman, 1995; Berkman & Syme, 1979).  In a recent review, (Cacioppo & 
Cacioppo, 2014) found that social isolation can have a negative impact on executive functioning, 
sleep, and mental and physical well-being, ultimately resulting in higher rates of morbidity and 
mortality. 
Social support as “the individual belief that one is cared for and loved, esteemed and valued, and 
belongs to a network of communication and mutual obligations” (Cobb, 1976, p. 300).  This too, 
can be lacking in individuals who suffer from rare diseases. Strategies to ameliorate perceptions 
of social isolation include various types of social support.  The need for this is illustrated by the 
European Union Committee of Experts on Rare Diseases (EUCERD) in their investigation into the 
social support needs of individuals with rare diseases (2012).  While the goal of this study is not 
to investigate the effect of interventions, the perceptions of social support are important to 
consider.  As a first step, the perception of social support in these individuals is critical into 
moving further in this work.   
 
Few published studies have explored the experiences of living with a rare disease; no published 
studies were identified that explored social isolation in rare lung diseases such as AATD or 
sarcoidosis.   Two studies conducted in the rare disease of scleroderma identified social isolation 
as a phenomenon experienced by these individuals.  Joachim & Acorn (2003) conducted a 
phenomenologic study to investigate the perspective of living with scleroderma and identified 
persistent themes of stigma and isolation.  In their study of scleroderma patients, Cinar and 
colleagues (2012) found similar themes, including social isolation.  Henderson and colleagues 
(2009) investigated the general psychosocial impact of living with Niemann Pick disease Type B, 
a rare lysosomal storage disorder; they also observed that those patients reported feelings of 
social isolation.  McGarvey and Hart (2008) surveyed over 200 general practitioners in Ireland; 
they found that 72% of GPs agreed that having a rare disorder gives rise to additional family 
problems and 28% felt that rare disorders can result in feelings of isolation.  No published studies 
have focused solely on the phenomenon of perceived social isolation in individuals living with rare 






Similar results were found when seeking to identify published studies on perceived social support 
in either one of these conditions.  No published studies were identified that explored perceived 
social support in sarcoidosis.  No such studies were identified which investigated perceived social 
support in alpha-1 patients, although Hoth and colleagues (2014) found that in over 400 
individuals with AATD, participation in support groups was associated with less ambiguity 
surrounding the disease. In particular, a statistically significant impact on ambiguity was found in 
those individuals who attended three or more support groups in the prior year compared with 
individuals who reported no such participation (b =−3.31, SE=1.29, p=0.010) 
 
Recognition of the importance of research into rare lung diseases has been growing (Gupta, 
Bayoumi, & Faughnan, 2011).  The contribution of the proposed research will explore and 
compare the perceptions of social isolation and social support in two rare lung disease groups 
from both the patient’s perspective, as well as quantitatively measure the magnitude of the 
phenomenon.  
Social isolation has been identified as a contributing factor for increased morbidity and mortality in 
various populations (Cacioppo & Hawkley, 2003; Cacioppo, Hawkley, Norman, & Berntson, 2011; 
Cornwell & Waite, 2009; Steptoe, Shankar, Demakakos, & Wardle, 2013).  Despite confirmation 
of perceived social isolation in Internet chat rooms, support group meetings, and limited studies of 
rare disease patients (Black & Baker, 2011; Coulson, 2005; Coulson, Buchanan, & Aubeeluck, 
2007; Lasker et al., 2005), there is a need for formal study that examines this phenomenon.  The 
contribution of this study will be significant because it will provide baseline data that can be 
utilized to design larger studies in more diverse populations of rare disease patients, with the goal 
of developing and testing interventions that can enhance social support and ameliorate the 
condition of social isolation.    
 
Despite the number of people affected by rare diseases, resources are lacking. Patients often feel 
isolated, unable to get the information and support they need (Colledge & Solly, 2012).  The 
contribution of this research is aligned with the mission of the NINR, and specifically, the need to 
“develop strategies to assist individuals and their caregivers in managing chronic illness, including 
analyses of caregiver burden and cost-effectiveness” (National Institute of Nursing Research, 
2011, p. 15).  The contributions from this research will provide preliminary insights into the 
management of the social isolation component of these rare, chronic diseases.  Findings from 
this study may be utilized to explore perceived social isolation and social support in other rare 
disease populations.     
 
Current clinical practice approaches the management of rare diseases primarily from the 
biomedical approach, seeking to manage clinical physiologic symptoms (Budych, Helms, & 
Schultz, 2012).  Less attention is given to the psychosocial management of the impact of these 
conditions.  There remains little published evidence regarding the psychosocial burden of rare 
diseases (Acorn et al., 2003; Barrow, 2011; Feinberg, Law, Singh, & Wright; Huyard, 2009; 
Joachim & Acorn, 2003; McGarvey & Hart, 2008; Schieppati, Henter, Daina, & Aperia, 2008), and 
no identified studies have explored perceived social isolation in these individuals.  As these 
patients may have significant needs and barriers to access to care (such as geographical 
distance from an expert provider), alternative interventions to ameliorate the negative 
psychosocial aspects of these conditions must be considered.  In rare diseases, there is an 
increasing importance and presence of the patient as an active participant in their disease 
management and decisions (Aujoulat, Young, & Salmon, 2012; Aymé, Kole, & Groft; Black & 
Baker, 2011; Johnson, Kirschenbaum, Mason, & Rush, 2005; Polich, 2012).   As such, this 
patient-centric focus calls for a parallel patient-centered research approach, such as interpretive 
phenomenological analysis (IPA) (Smith, Michie, Stephenson, & Quarrell, 2002).  Before 
designing interventions, it is prudent to seek out the voice of the patient, and the qualitative 
component of this study affords that opportunity.   
 
The proposed research is innovative because this is one of the first (likely the only) identified 
studies that explores perceived social isolation along with perceptions of availability of social 





the “voice of the patient” will be explored, via qualitative interviews, and findings from those 
interviews compared with the perceived social isolation scores on a quantitative instrument 
(validated in other adult populations, although not in rare diseases).  The investigator’s 
preliminary experience with previous qualitative interviews of AATD and sarcoidosis patients 
suggests that individuals grappling with these rare conditions are eager and willing to give voice 
to their concern. 
 
 
C. PRELIMINARY STUDIES____________________________________________ 
 
The investigator is a doctoral student in the College of Nursing at the Medical University of South 
Carolina, with a focus on the social burden of rare disease.  Although not an academically funded 
researcher, she has an established industry track record of over 17 years of pharmaceutical 
clinical research experience, the last twelve in pulmonary research.  For the past ten years, she 
has successfully led clinical teams in the design, execution and management of various early 
development studies, including two trials in the rare lung disease sarcoidosis, funded by her 
employer, and where she was an internal employee of the company.  Over the past four years, 
she have successfully translated that experience and knowledge to doctoral studies, where 
formal coursework is concluding.  As a doctoral student at the Medical University of South 
Carolina, she has been mentored in research involving rare disease populations under the 
tutelage of an experienced nurse scientist whose focus is also rare genetic conditions and a 
nurse scientist with expertise in community-based participatory research. The investigator also 
successfully completed an independent research project requiring travel to the EU, recruit, enroll 
and interview subjects for that project.  As a result of her pharmaceutical and  academic 
experiences, she is cognizant of the need to plan appropriately, execute precisely, and 
collaborate effectively and efficiently.  In summary, the investigator possesses a demonstrated 
record of accomplished and productive research projects in an area of high relevance for our 
aging population, and her expertise and experience have prepared me to lead the proposed 
project.   
 
D. RESEARCH DESIGN AND METHODS (including data analysis) ____________ 
 
Overall Strategy.  The mixed methods study design was informed by Creswell & Plano Clark 
(2011).  Semi-structured, individual interviews will be conducted to provide phenomenologic data 
for thematic analysis (Braun & Clarke, 2006) to describe individuals’ perceptions of social 
support, relationships with others, and preferences for support strategies.  A quantitative 
descriptive approach will involve participants’ completion of the Friendship Scale (Hawthorne, 
2006), a six-item Guttman scale that measures social isolation and  the Medical Outcomes Study: 
Social Support Survey (MOS-SSS), a 19 item version instrument that measures perceived 
availability of social support.  A convergent design will allow the investigator to collect and 
analyze two independent data streams in a single phase (Creswell & Plano Clark, 2011).  After 
merger, divergence, convergence and other relationships will be explored. 
 
Sample Size Determination.  Up to 275 participants will be enrolled in the trial, with the goal of 
an equal distribution of AATD and  sarcoidosis participants.  In this mixed-methods pilot study, all 
subjects will participate in the quantitative components and a subset (~30) will be requested to 
participate in the qualitative interviews, although the interviews are not a requirement.  If a robust 
response is realized for the qualitative inquiry at the beginning of the study, the invitation for the 
interview may be temporarily halted in order to allow the investigator to interview those interested 
participants soon after their agreement to be interviewed. This size is robust for a pilot qualitative 
approach; other qualitative studies of rare disease participants have enrolled less than 20 per 
group (Bogart, Tickle-Degnen, & Joffe, 2012; Joachim & Acorn, 2003).  Guidelines for sample 
size for studies using an interpretative phenomenological approach suggest that between 3-6 
participants per group is reasonable; this provides sufficient cases for analysis without the risk of 





rare disease groups have typically included less than 50 participants (Anderson et al., 2013).  
Some researchers have also suggested that saturation in qualitative interviews may occur early.  
Guest, Bunce, & Johnson (2006) evaluated data from a study involving sixty in-depth interviews 
with women in two West African countries and documented the degree of data saturation and 
variability over the course of thematic analysis. They found saturation occurred within the first 
twelve interviews, and further, basic elements for themes appeared as early as after the first six 
interviews. Based upon the previous points, the proposed sample size is a reasonable goal.   
 
The study will be introduced to potential subjects as a study that consists of two parts, an 
“interview” portion and a “questionnaire” portion.  For the purposes of this study, caregivers will 
not be included as part of the study population.  If subjects agree to participate in both parts, the 
preference is for the qualitative interview will be conducted first, followed by the quantitative 
component, but will be subject to participant availability and logistics.  In this study, caregiver is 
defined as the individual who acts as a support person for the individual with the rare condition; 
typical examples include a spouse/partner, other relative or friend who provides physical and/or 
emotional support (Burns, et al, 2005). 
 
• Eligibility Criteria 
o Inclusion 
! Participants will be eligible to participate in the study if they meet the 
following criteria: 
• Adult participants (male or female) ≥18 years of age 
• Self-report a physician diagnosis of AATD or sarcoidosis with 
pulmonary involvement 
• Self-reported ability to read and speak English 
• Have access to a computer with a valid email address (for 
purposes of completing instruments via REDCap) 
o Exclusion 
! Participants who self-report that they are caregivers, or have diagnoses 
other than AATD or sarcoidosis 
 
For the purposes of presenting the research design and methods, each one of the three 
individual aims will be presented individually: 
 
Aim #1:  To explore perceptions of the social impact of living with rare disease by 
assessing perceptions of social isolation, social support, connectedness, social 
participation and relationships in adults with two rare lung diseases, AATD and 
sarcoidosis, in an academic center and/or via the Web using one-on-one interviews.   
Introduction  In rare diseases, it is critical to obtain the voice of the patient (Patsos, 2001).  The 
objective of this aim is to elucidate individuals’ perceptions of social isolation, social support, 
relationships with others, and preferences for support strategies. This approach has been used 
successfully in other studies investigating living with a rare disease (Feinberg et al., 2013; 
Joachim & Acorn, 2003; Vitale, 2005).  To attain the objective of this aim, individual interviews will 
be conducted.  The rationale for this aim is gather information related to individuals’ experiences 
related to social support and social isolation, without imposing bias from predefined questions 
and/or categories.   
Data Collection.  For Aim #1, a semi-structured interview guide will be utilized for the purposes 
of conducting participant interviews.  Interviews may take place in a face-to face setting, via 
phone, or via Skype® (or a similar web-based videoconferencing program).  Following agreement 
to participate (via receipt of the Information for Survey Participants document) and during the 
interviews, the dialogue will be audio-recorded for the purposes of later transcription.  For those 
subjects who may be participating via telephone or Skype®  interviews, a script will be followed to 
ensure compliance to all verbal interview guidelines.  This type of interview approach is based on 
a flexible topic guide that provides a loose structure of open ended questions to explore 
experiences and attitudes (Pope, van Royen, & Baker, 2002).  In a hermeneutic approach to 





through the interaction between participant-respondent and interviewer (Lowes & Prowse, 2001).  
The interview script, comprised of eight questions, is designed to facilitate approximately 60-90 
minutes of dialogue.  The interviews will take place either face-to-face or via phone or Skype® for 
participants that are enrolled via the Internet.   
This Heideggerian hermeneutic approach (Lowes & Prowse, 2001) will shape the interview and 
describe from a participant perspective, individuals’ experiences in terms of living with a rare 
disease. Semi-structured questions and prompts are used to yield narratives centering on social 
isolation and/or social support (“tell me a little bit about the people you interact with during a 
typical day”; “tell me about who you could call on in times of need.).  This approach will allow the 
researcher to utilize previous knowledge gained to guide the inquiry (Lopez & Willis, 2004).   
Data Analysis:  Interviews will be transcribed verbatim.  The investigator will also maintain field 
notes to be used as a reference point and reflexive tool during data analysis.  After conduct of 
and transcription of the interviews, all data will be uploaded into nVivo10.  Following the 
guidelines prescribed by Smith et al., (2011), the investigator will seek immersion in the data by 
reading and re-reading each individual transcript.  Initial coding will occur on an exploratory level, 
followed by a more refined review looking for emerging themes (Smith et al., 2011). Interview 
transcripts will be coded line-by-line and codes will be developed themes and subthemes, as 
suggested by (Braun & Clarke, 2006).  After initial themes are identified, additional data 
abstraction will occur.   Following this inductive approach, data will be revisited to see if any 
reorganization of categories or themes should occur (Creswell & Plano Clark, 2011).  As an 
example of this approach, transcribed text that references support groups, online groups or 
advocacy involvement might code initially to a super-ordinate theme of “social support options”. 
Themes will be summarized using frequencies and percentages.  Data may be compared 
(between the two disease groups) using Fisher’s exact test, in order to identify substantial 
differences in the responses between the two populations.   
In addition, the number of attempted interviews compared with the number of completed 
interviews will be summarized. 
Expected Outcomes.  It is expected that participant interviews will yield information related to 
varying degrees of social support, perceived social isolation, and measures individuals have 
taken in the past to address their feelings.  It is also expected that some subjects may not have 
taken any steps to address their feelings of being socially isolated.  Analysis of themes is 
expected to generate inferences regarding the predominant themes in each sub-population, as 
well as the overall study population. 
Potential Problems and Alternative Strategies.  There are a number of potential problems that 
could arise as a result of the subjective nature of the qualitative approach.  Difficulty establishing 
rapport with potential subjects could arise.  For this particular study, the researcher will begin the 
interview with small talk and remind participants of their valuable contribution to the study.  Social 
desirability is another form of bias that may be present.  The population under study are both 
AATD and sarcoidosis participants who may suffer from the stigma of their disease, and may 
eagerly welcome the researcher’s attention. As DiLorio suggests (2005) some individuals may 
respond in an optimizing or satisfying approach, or conversely, acquiesce and act as a naysayer 
(p 44). Qualitative research is prone to bias due to the inherent preconceptions and attitudes of 
the researcher (Hewitt-Taylor, 2001).  Self-examination on the part of the researcher of their 
beliefs and attitudes can help to mitigate this risk.   
 
Aim #2: To compare the Friendship Scale and the MOS-SSS in individuals who have ever 
accessed compared to never accessed a support group in Alpha-1 and Sarcoidosis. We 
will also evaluate these tools as measures of perceived social isolation and availability of 
social support, respectively. 
 
Introduction. Pilot studies can be invaluable when assessing the feasibility of a planned design, 
the practicality of a given instrument, recruitment rates, and any data management issues that 
might occur, including response rates to questionnaires (Arain, Campbell, Cooper, & Lancaster, 
2010; Thabane et al., 2010).  This approach can be particularly useful when evaluating an 
existing instrument in a new population.   Hawthorne (2006) suggests that when measuring social 





advantageous, such as the Friendship Scale.  Response rates have been shown to be inversely 
correlated to questionnaire length (Edwards, Roberts, Sandercock, & Frost, 2004), although this 
relationship continues to be explored, and remains a topic of debate (Rolstad, Adler, & Rydén, 
2011).  The objective of this aim is to gain a sense of the magnitude of perceived social isolation 
and social support in the overall population, as well as within sarcoidosis and alpha-1 subjects.  
To attain the objective of this aim, subjects will be asked to complete the instruments via an 
electronic link to the REDCap site, where the instruments for the study will be located.  Although 
the preference is for qualitative interviews to be completed prior to completion of the instruments, 
the timeframe of when subjects are available for interviews versus completion of the instruments 
may not support this preference.  As such, subjects will be encouraged to complete the 
instruments at their convenience, irrespective of their willingness to participate in qualitative 
interviews.  The rationale for this aim is that comparison and contrast of scores will provide 
valuable insights into the magnitude of perceived social isolation, and also assess the feasibility 
of the instruments in these populations.   
 
Data Collection.  For Aim #2, four instruments will be utilized for the quantitative component of 
the study: a general demographics questionnaire, the modified Medical Research Council 
(mMRC) Dyspnea Score (to characterize perceived breathlessness), an instrument to measure 
perceived social isolation (The Friendship Scale) and an instrument to measure perceived 
availability of functional support, the Medical Outcomes Study – Social Support Survey (MOS-
SSS).   
 
The demographic instrument, designed by the investigator, will collect information related to age, 
ethnicity, race, disability status, pain, fatigue, frequency of leaving the home, gender, marital 
status, living situation, income, years since diagnosis, condition, genotype (if AATD), disease 
severity (sarcoidosis), familial history of the respective condition, participation in support or 
advocacy groups (and the number of meetings attended) and participation in outside activities, by 
study population as a whole, as well as by disease condition (Appendix 6).  
 
The second instrument is the modified Medical Research Council (mMRC) Dyspnea Score, a five 
item, standardized, self-administered scale to quantify the effects of breathlessness on everyday 
activities.  The scale is used to document the impact of dyspnea on the subject’s physical 
functioning.  A 5 point scale uses statements about perceived breathlessness graded from 0 to 4 
demonstrating increasingly severe loss of function (Bestall et al, 1999; Papiris et al, 2005).  
Dyspnea is rated in the present timeframe.  The scale has been used successfully with subjects 
aged 6 to > 80 years (Darbee and Ohtake, 2006) with a completion time of approximately 5 
minutes.   
 
The third instrument is the Friendship Scale, a six-item Guttman scale that measures social 
isolation (Hawthorne, 2006).  The psychometric properties of the scale in the validation study 
conducted in older adult populations living in various types of settings (nursing homes, hospital 
outpatients, older veterans, and community members) suggest that it has excellent internal 
structures as assessed by structural equation modeling (CFI = 0.99, RMSEA = 0.02), that it 
possesses reliability (Cronbach’s alpha = 0.83), and discrimination when assessed against two 
other short social relationship scales  (Hawthorne, 2006; Hawthorne, de Morton, & Kent, 2013; 
Nikmat, Hawthorne, & Al-Mashoor, 2013).   A subsequent validation study in individuals with low 
back pain showed similar results (Hawthorne et al., 2013).  The scale has been used in a study of 
over 3,000 community-dwelling residents of Australia, ranging in age from adolescence to the 
elderly.  Use of the Friendship Scale in any rare disease population has not been identified in the 
published literature.  However, the consistent psychometric results of the scale in diverse 
populations suggest that the scale may possess similar validity in the populations under 
consideration, although this needs to be explored.   
 
Tests of concurrent discriminant validity suggest it is sensitive to the known correlates of social 
isolation (Hawthorne, 2006).  The scale covers both critical aspects of social isolation: perceived 





social isolation and the other three assess perceived loneliness. Scores for each item range from 
zero to 4; an individual’s total score on the instrument can range from zero to 24.  Scoring is by 
simple summation. Cutpoints to classify different levels of social isolation are as follows:  
• 0-11: Very socially isolated 
• 12-15: Isolated or with a low level of social support  
• 16-18: Some social isolation or some social support  
• 19-21: Socially connected  
• 22-24: Very or highly socially connected  (Hawthorne, 2006). 
 
Finally, the fourth instrument is the Medical Outcomes Study: Social Support Survey (MOS-SSS).  
This is a 19 item version instrument that measures perceived availability of social support. It 
contains four domains to assess perceived availability of social support, including (1) emotional/ 
informational support, (2) tangible support, (3) positive social interaction and (4) affectionate 
support (Sherbourne & Stewart, 1991).  Responses are given by the subject using a 5 point 
Likert-type scale, and range from “none of the time” to “all of the time”.  Scores range from 0-100 
with higher scores indicating more perceived support.  The MOS-SSS has been utilized 
extensively in various populations (Carod-Artal, Ferreira Coral, Trizotto, & Menezes Moreira, 
2009; Cuijpers, 2001; Duncan et al., 1997; Sherbourne & Stewart, 1991), and more recently, in 
studies of social support in COPD patients (Zijing et al., 2014)  
 
All instruments will be completed by the subjects, at a time convenient to them and accessed via 




The sample size calculation is based upon the Friendship Scale.  In the general population, the 
mean total score for the Friendship Scale was 21 (SD 3.47) (Hawthorne, 2006)( We hypothesize 
that the total Friendship scale score reflecting social connectedness for the entire study 
population is 20 representing a difference in total scores of 1 point on the Friendship scale.  To 
have 80% power to detect a difference of 1 point in total scores between the general population 
and the study sample of alpha-1 and sarcoidosis patients, assuming a common standard 
deviation of 4.0 for alpha=0.025 (one-tailed test), 126 subjects  are required.  The assumption of 
a lower score for the disease groups under study is based upon references in the literature which 
suggest some degree of social isolation in these individuals (Colledge & Solly, 2012), although 
that has not been formally tested. For further comparison of social connectedness between the 
two disease subgroups (alpha-1 versus sarcoidosis) with 60 participants per group we will have 
80% power to detect a two point difference in total Friendship scores between the groups 
assuming a common standard deviation of 4.0 for a two-tailed t-test (alpha=0.05). 
 
 
Data Analysis:  
 
Subjects will complete the questionnaires in REDCap.  Data from REDCap will be exported to 
SPSSv22 for analyses. 
o Descriptive statistics will be computed on the demographic and clinical characteristics 
of the study population.    
o Where appropriate, and for categorical variables including ethnicity, race, gender, 
marital status, living situation, income, disease condition, genotype (if AATD) or 
staging (if sarcoidosis) activities, participation in support groups, hearing and 
sight status, and challenges with stair climbing and/or dressing or errands, 
frequencies (both absolute and relative) will be reported for each item. 
o For ordinal variables, such as years since diagnosis and income, frequencies 
(absolute and relative) will be reported. 
o For the continuous variables of age, number of years since diagnosis, pain and 
fatigue day counts, and days that the subject has left their house, measures of 





o Disease groups will be compared with respect to their demographic and clinical 
characteristics using t-test and chi-square tests as appropriate for continuous and 
categorical variables, respectively. If non-normality is observed appropriate non-
parametric tests will be used instead.  
o Feasibility of the instruments will be examined by assessing recruitment rates, 
completion rates and time to completion.  Participants will be asked to rate both 
instruments in regard to ease of completion (very easy to complete/easy to 
complete/hard to complete/very hard to complete) (see Appendix 5).   
o Recruitment patterns will be examined 
! Numbers of potentially eligible subjects versus number who consent to 
participation will be reported as proportions  
• Number of completed instruments versus number of attempted 
instruments will be reported using proportions. 
• A “completed” instrument is defined as an instrument where 
>90% of the items have been responded to by the subject. 
o For the Friendship Scale, the subject will enter a 
response to the 6 questions 
o For the MOS-SSS, the subject will enter a response to 
the 19 items 
• For those instruments with missing scores, missing values will be 
assumed to be missing at random, and imputed using the 
Individual mean imputation approach.  
o The imputed value is the calculated mean of a given 
subject's complete responses to other questions. If a 
participant has 2 missing responses, the values are filled 
with the calculated average of the remaining completed 
18 questions (Shrive, Stuart, Quan, Ghali, 2006).   
o Faciliators and barriers to recruitment will be examined in anticipation of their 
impact on subsequent trials 
! Use of patient advocacy contacts, clinician-experts, social media 
outreach will be considered and reported as well as the number of 
enrolled participants that come from these various methods   
! For those subjects who participate in the qualitative portion of the study, 
prompts will explore the reasons for participation. 
o Differences between completion rates will also be examined.   
o Completion rates will be summarized and compared using an ANCOVA model by 
ease of completion (easy/not easy), mode of delivery (‘live” versus electronic) 
and disease population (sarcoidosis / alpha-1) 
! The Kruskal-Wallis test will be used to compare completion rates by 
income level.  Chi-square, df and significance will be reported 
o Ease of completion will be summarized and compared using the Cochran–
Mantel–Haenszel test, stratifying on income and disease.  
o Reliability 
o Reliability will be explored by calculating Cronbach’s alpha for the  overall 
population and each disease population.  For the Friendship Scale, a will be 
reported for the overall scale.  For the MOS-SSS, a will be reported for both the 
subscales as well as the overall instrument.   
o Validity 
o Content validity will be assessed by presenting the two scales to three experts 
in the field prior to having any subjects complete the questionnaires:  (1) a 
sarcoidosis expert, (2) an alpha-1 antitryspin deficiency expert and (3) an expert 
in the area of instrument development.  Although not expert in the field of patient-
reported outcomes, the scales will be presented to two expert, disease-specific 
clinicians to assess clinical relevance.  
o Concurrent validity will not be explored at this time due to the limitations of the 





o Convergent validity will be explored by correlating scores on the Friendship 
Scale with scores on the MOS-SSS; it is hypothesized that higher Friendship 
Scale scores will correlate to lower MOS-SSS scores (indicating less perceived 
support). 
o Social isolation and social support scores:  
o For the Friendship Scale, negatively worded items (items 1, 3 and 4) will be reverse 
scored so that their valence matches the positively worded items (Hawthorne, 2006).   
o For the MOS-SSS, scores for each subscale will be obtained by  
o First, individually calculating the average of the scores across all respective items 
in each subscale.  
o An overall support index will be calculated by summing the average of  
! the scores for all 18 items included in the four subscales, and  
! the score for the last item of the scale, which asks the subject if they 
have “someone to help them keep their mind off of things”.  This last item 
is not included in the 4 subscales  
o Finally, scores will be transformed to a range of 0 to 100 using the developers’ 




! Mean total scores (with 95% CIs) will be calculated for the pooled study population 
(alpha-1 and sarcoidosis subjects) for both the Friendship Scale and MOS-SSS.   
o Subsequently mean total scores (with 95% CIs) will be calculated for the 
individual disease groups for both scales.  The mean scores of each disease ;) 
o group will be compared with the mean score for the overall study population. 
o The pooled study population will be dichotomized into individuals who have 
accessed online or face-to-face support groups and those who have not 
accessed such groups.  
! We will compare mean total scores (with their 95% CIs) for both the 
Friendship Scale and MOS-SSS to determine if there is a difference 
between the groups of subjects who have accessed compared to not 
accessed online or face-to face support groups. , 
! In addition we will compare the means for these tow groups stratified for 
disease state. Independent t-tests will be used to examine the 
differences in the Friendship Scale and MOS-SSS scores between 
individuals who have accessed online or face-to-face support groups and 
those who have not. 
! Results will include the t-statistic, the df, and the degree of significance. 
! If non-normality is observed, alternatively, Wilcoxon rank-sum tests will 
be utilized to examine the difference in the Friendship Scale and MOS-
SSS scores between individuals who report access to online or face-to-
face support groups.   
• Results will include W, the z-score and the significance level, 
along with the median score.  Mean scores (and SDs) will also 
be reported, if careful consideration of outliers merits inclusion of 
the value.   
! Exploratory logistic regression will be used to determine whether any of the demographic 
or clinical characteristics might be predictive of higher/lower social isolation or social 
support scores.  
o The Friendship Scale will be dichotomized into those who were very isolated, 
isolated, and with some isolation [range of scores 0-18]  versus the socially 
connected and very socially connected [range of scores 19-24]) (Hawthorne, de 
Morton, & Kent, P. (2013). 
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o The MOS-SSS will be dichotomized to indicate those who perceive low-normal 
social support (below 75th percentile) or high social support (above or equal to 
the 75th percentile) (Sherbourne, Meredith, Rogers and Ware,(1992).  
! Odds ratios (with 95% CIs) for each predictor will be calculated and presented. Of 
particular interest are age, sex, race, education level, pain scores, and disease severity 
indices.  
o Missing values will be assumed to be missing at random, and will be imputed 
using the multiple imputation procedure available in SPSS.   
  
 
95% confidence intervals will be calculated and presented to provide measures of precision of the 
outcome estimates.    
 
Expected Outcomes.  It is expected that the analyses of the quantitative scores will generate 
inferences regarding the magnitude of perceived social isolation in each sub-population, as well 
as the overall population. There may also be some outlier scores; these scores will be examined 
individually, as well as in the context of the individuals who completed those respective 
instruments.   
 
Potential Problems and Alternative Strategies.  The expectation is that participants in the 
overall population will report some degree of social isolation, as measured by the Friendship 
Scale.  The literature review, albeit brief, supports this expectation.  However, there is the remote 
possibility that this is not the case, and that some subjects do not report perceptions of social 
isolation.  In that event, the demographic questionnaire and qualitative interviews would be 
reviewed for confirmation of participation in support groups, advocacy efforts and/or strong 
family/friend support.  These potentially confounding variables could also explain why some 
individuals do not report perception of isolation.    
 
Various measurement errors can occur with the use of the Friendship Scale.  Random error can 
occur because of noise or distraction and as a result, the participant enters incorrect responses.  
Idiosyncratic error also is possible, since three of the item responses are reversed. It is possible 
that participants could indicate the wrong response due to the preceding response.   The potential 
for social desirability response bias exists, in that participants might provide responses for which 
they think that the researcher will approve. To mitigate this risk, the researcher will sit quietly with 
each participant, allow a dialogue to occur, and remind them that the researcher is not there to 
judge, but to collect the most precise data possible. “Faking bad” occurs when a participant 
answers in a more negative manner because they think that they might benefit from it (Di Lorio, 
2005).  The researcher has included information in the Information for Survey Participants form 
that details the expectations of the participant and the consequences of participating in this 
research study.  The Friendship Scale has a 4-week recall period.  This can be challenging, 
especially if the participant responds quickly to the question, rather than considering the recall 
period (Di Lorio, 2005).  One way to mitigate this would be to conduct cognitive interviews to 
understand what participants are thinking as they respond to the questions (Nápoles-Springer, 
Santoyo-Olsson, O'Brien, & Stewart, 2006).  However, this would not be optimal in this case due 
to the time constraints of the current study.  The researcher will remind each participant of the 4-
week recall period prior to the participant completing the scale.  The scale is self-administered by 
the participant.  As DiLorio (2005) suggests, an introductory cover letter may help to ameliorate 
incorrect responses, by helping to focus the participant and put them in the proper frame of mind.  
Environmental factors that could cause measurement error could be an overcrowded room, 
where the participant might not be comfortable (for the face-to-face cohort) or lack of familiarity 
with the computer (for the web-based cohort).   
 
Aim #3: Triangulate the survey and interview results to identify areas for development of 






Introduction.  Triangulation of data can enhance completeness and trustworthiness of the work, 
in addition to providing for a more in-depth analysis of the findings.  The approach of combining 
closed-ended questionnaires, like the Friendship Scale, with qualitative interviews, such as the 
one proposed, is one of the most common mixed-methods approaches in the literature (Creswell 
& Plano Clark, 2011).  As this parallel, convergent, mixed-methods design is intended to be 
exploratory in nature, the objective of the triangulation of data from both the quantitative and 
qualitative strands is to combine or link the findings into meta-inferences of the study findings as 
a whole (Teddlie & Tashakkori, 2009).  To attain the objective of this aim, after concurrent data 
collection, both data streams will be independently analyzed.  Based upon the findings, specific 
dimensions will then be identified on which to compare the findings (Creswell & Plano Clark, 
2011). The rationale for this aim is that subjective narratives may identify areas for further item 
development not captured in the Friendship Scale and provide insights into intervention 
development.  When the triangulation of data is completed, it is the investigator’s expectation that 
the results will yield information to provide for further refinement of subsequent larger studies, 
with an eye towards identification of possible strategies that can ameliorate perceived social 
isolation.   
 
Triangulation:  
This project combines qualitative and quantitative data from multiple data sources to support a 
preliminary, yet comprehensive evaluation of the perceived social impact of living with a rare 
disease. Triangulation of data and methods provides a more holistic and contextual 
representation of the phenomenon under investigation, and reveals the varied dimensions of the 
phenomenon, with each source contributing an additional piece to the puzzle. In using 
triangulation, bias can be minimized and validity enhanced.  
 
In this study, the investigator will implement the process of conceptual triangulation described by 
(Foster, 1997). Conceptual triangulation involves "a search for logical patterns of relationship and 
meanings between the variables measured by either or both qualitative and quantitative 
methods." (Mitchell, 1986, p25) This process is designed to achieve a more complete and 
contextual portrayal of the phenomenon of interest. The process of conceptual triangulation 
involves five steps: 1. conducting qualitative and quantitative research true to the paradigmatic 
assumptions of each methods,2. distinguishing pertinent results within each methods, 3. 
examining confidence in the results, 4. developing criteria for inclusion of results in the conceptual 
model, and 5. constructing one or more preliminary conceptual models of the social impact of a 
rare disease.  Due to the limitations of this dissertation study (sample size, study populations, 
time and budget constraints), the development of such a model may not be possible, but will be 
considered throughout all phases of the research process.   
 
Research Design.  Following completion of Aims #1 and #2, data will be compiled for 








As data will have been reviewed separately for Aim #1 and Aim #2, this third Aim will employ 
revisiting the data as a whole, to assess for convergence of divergence of findings.   
 
Expected Outcomes.   This is the first known mixed methods study to explore any psychosocial 
phenomenon in rare disease patients. It is anticipated that the results may reveal some degree of 
social isolation in both groups, and the isolation may be directly correlated with disease severity 
(more severe disease equates to increased perceived social isolation).  Phenomenological 
findings may add rich information regarding the characteristics of perceived social isolation that 
cannot be measured with the Friendship Scale.  In addition, it is anticipated that qualitative 
responses detailing participants’ previous experiences with support groups or activities will inform 
future studies designed to investigate various interventions.  Themes that reflect coping with or 
decreasing social isolation will be used in hypothesis generation and a later process of 
intervention mapping (Kok, Schaalma, Ruiter, van Empelen, & Brug, 2004).  Inferences from the 
QUAN and QUAL datastreams will inform meta-inferences for the overall study.   
 
E. PROTECTION OF HUMAN SUBJECTS_________________________________ 
 
1.  RISKS TO THE SUBJECTS  
 
Human participants affected by rare lung diseases can experience a number of various 
psychosocial challenges related to their rare disease, including perceptions of social isolation.  
The cause of these perceptions is the topic of this proposed research.  Approximately 275 human 
participants (with the goal of enrolling an equal number of sarcoidosis and alpha-1 subjects) will 
be invited to take part in this study to assess and compare perceptions of social isolation.  Human 
participants will take part in individual interviews as well as completion of a short, quantitative 
questionnaire.  The investigator will be the sole individual conducting the interviews and 
administering the questionnaire at a single time point.  Interviews are planned to be conducted 
face-to-face; however, telephone or Skype interviews may be utilized.  
Subject Population Characteristics. The collaborating academic institution, the Medical 
University of South Carolina, is a large academic institution with established clinics that serve a 
large population of alpha-1 and sarcoidosis patients, respectively.  The investigator has 
established previous academic relationships with the collaborating physician, Dr. Charlie Strange 
(MUSC).  The Alpha-1 Research Registry, located at MUSC, has currently enrolled over 3300 
individuals with Alpha-1 Antitrypsin Deficiency (Alpha-1 or AAT Deficiency) or a carrier phenotype 
willing to participate in Alpha-1 research.  The Registry was established in 1996 by the Alpha-1 
Foundation in accordance with recommendations of the World Health Organization, to facilitate 
research initiatives and promote the development of improved treatments for Alpha-1  Web-based 
Method Data Collection Type of Triangulation Method of Analysis Purpose/Goal 
Qualitative Within Method   
Subject Interviews Investigator Audio-recorded, , 
transcribed, analyzed for 
themes 
Deepening understanding 
of subjective experiences 
Field notes Investigator Analysis of text Document observations, 
scenarios, not easily 
interpreted from text 













Triangulation of  
qualitative data with 
results of the scale to 
determine if interview 
findings are reflected in 






support groups that the investigator belongs to, (including the Alpha-1 support group and the 
Sarcoidosis Online Sites groups) have more than 600 and 1800 members, respectively. In 
addition, subjects may be recruited via postings on the NORD (National Organization for Rare 
Disorders) and INSPIRE (an online community for individuals with rare conditions) websites.  It is 
anticipated that the average age will be 50 years, ~60% female, ~40% male, approximately 40% 
black (primarily driven by the sarcoidosis population), 60% white.  
 
We anticipate <1% of the population will be Hispanic, which reflects the ethnic make-up of the 
recruitment area. We will include English-speaking participants only due to the pilot nature of the 
study, limited resources and the special needs of bilingual and culturally sensitive 
protocol/materials. Children will not be included as sarcoidosis is generally limited to adults, and 




Targeted/Planned Enrollment Table 
 
Total Planned Enrollment 275 
 
TARGETED/PLANNED ENROLLMENT: Number of Subjects 
Ethnic Category 
Sex/Gender 
Females Males Total 
Hispanic or Latino 2 3 5 
Not Hispanic or Latino 200 70 270 
Ethnic Category: Total of All Subjects* 
 
 
Racial Categories  
American Indian/Alaska Native 0 0 0 
Asian 0 0 0 
Native Hawaiian or Other Pacific Islander 0 0 0 
Black or African American 50 50 100 
White 110 65 175 




b.  Sources of Materials  
 
Materials obtained from the participants include questionnaires and interviews. Demographic data 
includes information related to age, ethnicity, race, disability status, pain, fatigue, gender, marital 
status, living situation, income, years since diagnosis, condition, genotype (if AATD), disease 
severity (sarcoidosis), familial history of the respective condition, participation in support or 
advocacy groups (and the number of meetings attended) and participation in outside activities, by 
study population as a whole, as well as by disease condition (Appendix 7). These data will be 
collected from interviews by the investigator to further characterize and describe the sample. The 
questionnaires (demography, the Friendship Scale, the MOS-SSS, and the mMRC Dyspnea 
Scale)  can be done in less than 30 minutes to reduce participant fatigue and burden. Participants 
will enter their own data into REDCap via an electronic link sent to each participant via email. 
Access to the REDCap database will be given to the investigator’s advisor. 
 
c.  Potential Risks  
 
There are potential risks inherent to any type of interview approach such as psychosocial impact 
and increased focus on the negative aspects of any condition. There is minimal risk to the 





participants will respond to interview, demographic and scale questions as described above.  
Breach of confidentiality is a potential risk.  It is possible that individuals familiar with study 
subjects at a particular research site could identify those subjects who participate in this study.  
Personal identifying information will not be stored with data.   
 
F.  ADEQUACY OF PROTECTION AGAINST RISKS  
 
a.  Recruitment and Informed Consent 
 
Recruitment.  Access to participants will be facilitated through an established relationship with a 
clinician expert located at the Medical University of South Carolina.  In addition, the investigator 
has established a network of patient contacts who participate in Web-based support groups (such 
as www.Inspire.com and NORD (National Organization for Rare Disorders 
(www.rarediseases.org) and other rare disease initiatives.  Representatives from these 
organizations have been contacted and are amenable to posting notification of the study on their 
Web pages and/or Facebook pages.  Prior to study commencement, these individuals have been 
contacted and informed about the study with the intent of collaborating with them as a source of 
potential participants.  Web-based recruitment may be utilized to enroll a portion of the 
participants in the study.  In rare disease research, the internet has been a key and expanding 
method for recruiting clinical study participants and publicizing new studies and/or areas of focus 




The study seeks a waiver of informed consent, since no interventions are being performed.  
Subjects may be accessed via the following avenues: 
• Dr. Charlie Strange at MUSC 
• The Inspire website,  
• The NORD Facebook page 
• Via previous patient contacts known to the investigator, including patient support 
groups.   
 
Study Procedures 
All potentially interested subjects will be provided with the email and phone number of the 
investigator. 
• They will be asked to contact the investigator for further information, and to provide their 
first name, last initial, contact email and phone number.  
• For these subjects, a prenotice letter will be sent (via email) that acquaints them with the 
study and explains the purpose of the current data collection.   
o A second follow-up email contact and a follow-up phone call (where possible) will 
be used to bolster participation of those who do not respond to the initial mailing.  
• The prenotice letter will be followed with by an email containing an electronic link 
directing them to the REDCap link which will include an Information for Survey 
Participants document, a patient information module (requesting first name, last initial, 
phone number, email and the electronic versions of the instruments.   
Quantitative Procedures (REDCap Survey) 
• Once entering the REDCap site, the first module that the subjects will see is the 
Participant Information Survey (5 items), which collects the first name, last initial, email 
address and phone number. 
o In addition, the last  question in the Participant Information Survey section of the 
REDCap site asks the subjects specifically if they would be willing to participate 
in the qualitative interview. 
o “Would you be willing to participate in a short (30 minute) interview with the 
investigator, in addition to responding to the surveys here?”   





! They can continue through the REDCap site, complete the 
survey/instruments, and be contacted by the investigator to determine a 
mutually agreeable time to be interviewed  
! Alternatively, the can opt to complete the interview prior to completing 
the surveys. 
• Both options are at the discretion of the subject, and intended to 
decrease respondent burden 
• The investigator receives notification when a new subject has 
accessed the REDCap site, and so will be made aware of any 
new/potential participants 
! If the interview is conducted in person, it may be conducted either at the 
MUSC clinic site of Dr. Strange, or at a mutually agreeable location (for 
both subject and investigator) if the participant is local to the investigator. 
! The interview will be audio-recorded and transcribed at a later date for 
purposes of qualitative coding and analysis. 
! No protected health information (PHI) will be collected, other than the 
participant’s first name, last initial, and diagnosis.   
o If the participant responds “no” 
! They can continue through and complete the online surveys. 
 
• The next module that the subjects will complete is the Demography module (26 items), 
which asks questions about the subject’s age, race, levels of pain, fatigue, impairments of 
hearing, vision, concentration, mobility, ability to perform activities of daily living, gender, 
marital and living situation status, levels of income and education, disease and duration 
of condition, participation in support groups and other activities. 
• The third module that the subjects will complete is the modified Medical Research 
Council (mMRC) Dyspnea Scale, a 5 item scale that asks the subject about their level of 
perceived dyspnea 
• The fourth module is the Friendship Scale, a 6 item scale that inquires about the subject’s 
perceptions of social isolation 
• The fifth module, the Medical Outcomes Study: Social Support Survey (MOS-SSS), is a 
19 item instrument that measures perceived availability of social support. It contains four 
domains to assess perceived availability of social support, including (1) emotional/ 
informational support, (2) tangible support, (3) positive social interaction and (4) 
affectionate support 
• Subjects  will be asked about the ease of completion for both the Friendship Scale and 
the (MOS-SSS), by ranking the level of difficulty from “very easy to complete” to “very 




Although it is preferable for subjects to be interviewed prior to completing any of the instruments, 
in order to minimize bias that the instruments may impose, it is likely that subject interviews may 
take place after respective subjects complete the surveys.  Approximately 30 subjects will be 
interviewed.  Measurement generation will begin by collecting a range of patient perspectives 
regarding feelings of social isolation and social support. Interviews will be facilitated by a semi-
structured interview guide, allowing opportunity for interviewees to share additional experiences 
not addressed by the questions.   
Location/Duration/Approach of Individual qualitative interviews  The investigator will be the 
sole conductor of the individual semi structured qualitative interviews; following a prepared topic 
guide. It is anticipated that 30 subject interviews will allow for  saturation of the topics of social 
isolation and social support. Interviews will be audiotaped at the time of conduct.  Interviews will 







Following completion of the subject interviews, all information will be transcribed and uploaded 
into nVivo for further qualitative analysis.   
 
As we are requesting a waiver of signed consent, this Information for Survey Participants - 
Statement of Research document will be provided and it will describe the goals of this study and 
will contain all other required elements of consent.  It also notes what will be asked, how long it 
should take to complete, assurance of confidentiality, and that remuneration  - in the form of entry 
into a drawing for an Apple iPad – is optional for participants.  Participants will be informed that 
consent to participate is implied by return of the completed survey.   
 
 
b.  Protection against Risk 
 
Minimal risk is anticipated. In the event of an unexpected event as a result of participating in the 
interviews, the participant will be instructed to contact the investigator. Based on the experience 
of the PI, it is anticipated that the risk of AEs will be acceptably low. In the event of an AE, it will 
be recorded and submitted to the IRB and PI according to institutional procedures. The PI and 
PI’s doctoral advisor will review all AEs.  
 
The Information for Survey Participants document assures confidentiality of all information 
obtained during the study.  In particular, confidentiality of subjects will be guarded by conducting 
data collection (interviews and questionnaire instrument administration) in a private clinical 
setting/location that will be secured by the investigator in advance of the planned meeting.  The 
confidential data will be deidentified for purposes of transcription and analysis. Each subject will 
be assigned a unique participant code known only to the investigator and maintained in a locked 
fashion.  Breach of confidentiality may be considered an adverse event, and may be reported to 
the IRB.   Maximal efforts will be undertaken to ensure the safety of all participants. Participants 
will be instructed on how to access the, PI or in the event of study-related questions. In the event 
of study-related illness or injury, participants will be instructed on how to access health care. 
Participants will be given a card with the investigator’s name and phone numbers to contact in the 
event there is a problem.  
 
All personal information, such as phone numbers or emails for follow up, will not be connected to 
any data and will be discarded after interviews are complete and the Apple iPad is distributed. 
Each subject will be assigned a unique study ID number for the purposes of linking a unique 
person with a given set of data.   
 
There are no social or legal risks associated with participation in the study. Confidentiality will be 
maintained for all other collected data.  The subject identification and enrollment log will be 
treated as confidential and will be filed by the investigator in the study file. To ensure subject 
confidentiality, no paper copies will be made. All reports and communications relating to the study 
will identify subjects by assigned number.  All electronic files will be protected via encryption, and 
the password(s) to those files accessible to the investigator and the investigator’s doctoral advisor 
only.   
 
 
G.  POTENTIAL BENEFITS OF THE PROPOSED RESEARCH TO THE SUBJECTS AND 
OTHERS  
 
There is no direct benefit of the research to the subject. However, the disclosures of the 
participants will inform future measurement of perceptions of social isolation and other social 
burdens not yet recognized or addressed by the scientific community. Measurement develops 








H.  IMPORTANCE OF THE KNOWLEDGE TO BE GAINED  
 
This study will provide valuable information for the purposes of informing future studies designed 
to investigate interventions that can ameliorate social isolation in individuals with Alpha-1 
antitrypsin deficiency, sarcoidosis, and potentially other rare lung diseases. In addition, the 
knowledge gained is important because these sample communities could be representative of the 
needs of other rare disease populations 
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Qualitative Narratives:   
Alpha-1  
Qualitative Narratives:   Sarcoidosis  
Social 
Support       
[as measured 
by the       
MOS-SSS 
Total Score] 
63.8                        
(some lack of 
support) 
66.4                       
(some lack of 
support) 




• “And my kids they are 
not very sympathetic; 
there is no real empathy 
there from kids.  They 
know I have this 
problem but they really 
are not too interested or 
involved.” [FS 4; MOS-
SSS 1.3] 
• “I couldn’t be happier 
with the Alpha-1 
support system that is in 
place.  I have just 
involved, I am going to 
be involved in a study 
in St. Louis for the 
liver.”[FS 24; MOS:  
96.1] 
• “There is no support 
group where I live.  It’s 
like two hours away.  I 
do have good support… 
I do a lot of online.”[FS 
18; MOS: 64.5] 
• “I have good support 
within my family and 
• “I am on the two Facebook pages… But to be 
honest with you I try to stay off those 
because I get depressed because there's 
people in worse condition than I am”[FS:  
23; MOS:  96.1 
• “I am also a member of the Peer Support 
Unit of Boston Police Department even 
though I am retired, and we’ve got resources 
there that I can call, contact you know I can 
contact and call upon if I need support.” 
”[FS:  23; MOS:  96.1] 
• “I feel fortunate that I have that, and like I 
said the biggest thing for me with the, was 
the Facebook pages…social media can be a 
good thing… just when I look at people that 
are worse off than me I am like this really 
isn’t for me” [FS:  23; MOS:  96.1] 
• “I have some friends on Facebook … I can 
talk freely to and I feel– … they tend to be 
judgmental or they tend to just, I am sicker 
than you and I am this, there is a lot of “I” 
going around, I don’t like a lot of the groups 
on Facebook, so I have five or six people 
that I talk to regularly.”[FS:  15; MOS:  
35.5] 


















Qualitative Narratives:   
Alpha-1  
Qualitative Narratives:   Sarcoidosis  
good support – the only 
thing that I miss is 
being able to have 
somebody go, yeah, I 
totally understand, but 
much you may know 
me the side of the other 
thing.”{FS 18; MOS: 
64.47] 
• “I’m on Facebook and I 
have got hundreds of 
friends on Facebook 
and they all seem to 
know that I have this 
double thing going on.  
I don’t care, I’m open 
about it.  It’s how I get 
my support”[FS 17; 
MOS: 64.47] 
and there are only five people in my support 
group and in January nobody came to my 
meeting, I had a guest speaker, so totally 
embarrassed that nobody came…I want to 
just to reach out to everybody and like, are 
you going to come if I have a meeting 
because I don’t want to come and sit there 
by myself for an hour.” [FS:  15; MOS:  
35.5] 
• “..The XX site has gotten a pretty unhealthy 
lately.  So we pulled off about eight months 
ago and said let's create the little Facebook 
group and private group.  This little tight 
group is seven of us who always seem to 
respond to each other’s post and always 
seem to be very supportive of each other just 
had to make a little offset group…” [FS:  15; 




by the       
Friendship 
Scale] 










14.5                         
(isolated or with 





• “I have a very small 
core support group of 
family and friends that 
know my condition that 
I feel comfortable being 
around because they 
know why I am slow, 
• “…. support is very important, you do feel 
very isolated with this disease..there is not a 
lot out there. There is not a lot of medical 
information out there.” [FS:  15; MOS:  
35.5] 
• “I have some [friends] that talk to me on 
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why I get short of 
breath.  But mostly I 
don’t have a social life 
anymore”[FS:  14.4; 
MOS:  81.6] 
• “I still go as much as I 
feel that I can, I still 
isolate myself more 
than average person 
probably that’s much 
better than what I want 
to do.”[FS 9; MOS: 
13.2] 
• “Let me tell you what I 
call this disease.  I 
called it the lonely 
disease and that 
probably sums it up in a 
nutshell.” 
• “Mine (life) has been 
impacted negatively 
very much and I know 
and it gets a little bit or 
it gets more isolated 
you know as time goes 
by”.  [FS 17:  MOS:  
gone; I don’t have the common things that 
we used to working together.” [FS 7; MOS 
11.8] 
• “I didn’t talk to people for months on end 
because it was just so depleting to even 
have a talk”[FS 20; MOS:  89.5] 
• “I’m rarely out instead of rarely in the 
house, now I’m rarely out of the house. I am 
very much -- I almost feel hermitish, 
because I know that if I -- even if I do feel 
good and I go and do one of those things, I 
will have trouble for the next two days after 
that with pain”[FS 15; MOS:61.8] 
• Mostly there are days that are so lonely and 
so – just – that I have actually said to my 
physician I promise you I cannot live the 
rest of my life this way and I meant every 
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64.5] 
